<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">41226855</PMID><DateCompleted><Year>2025</Year><Month>11</Month><Day>13</Day></DateCompleted><DateRevised><Year>2025</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>21</Issue><PubDate><Year>2025</Year><Month>Oct</Month><Day>22</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Placental Thickness Correlates with Severity-Weighted Fetal Dysfunction in the Third Trimester.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">7461</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm14217461</ELocationID><Abstract><AbstractText><b>Background:</b> Placental thickness has been associated with adverse perinatal outcomes, but the relationship to specific fetal abnormalities seems to not yet be well understood. This study investigates whether increased placental thickness correlates with the severity of fetal cardiac and extracardiac conditions using a structured classification and severity-weighted scoring system. <b>Methods:</b> We undertook a retrospective analysis of 1452 fetal echocardiograms conducted during the third trimester at a tertiary referral institution from the years 2022 to 2025. The diagnoses were categorized into four distinct classifications: congenital heart anomalies, cardiac dysfunctions, extracardiac malformations, and extracardiac dysfunctions. Each diagnostic category was allocated a severity weight predicated on established fetal and neonatal mortality risk literature. The evaluation of placental thickness was regarded not merely as a persistent variable but also categorized into three distinct classifications: thin (&#x2264;40 mm), intermediate (41-69 mm), and thick (&#x2265;70 mm). The examination of correlations was performed utilizing Spearman's &#x3c1;; comparative evaluations among the groups were conducted employing the Kruskal-Wallis and Mann-Whitney U tests. <b>Results:</b> Placental thickness revealed a moderate positive correlation with weighted extracardiac dysfunctions (&#x3c1; = 0.36, <i>p</i> &lt; 0.00001), displayed a comparatively weaker yet statistically significant association with cardiac dysfunctions (&#x3c1; = 0.13, <i>p</i> = 0.01). Fetuses identified by increased placental thickness (&#x2265;70 mm) exhibited notably higher mean scores for both cardiac and extracardiac dysfunctions. Within the cohort exhibiting thick placentas, 25.8% displayed extracardiac dysfunction scores surpassing 0.3, in contrast to only 7.7% within the cohort with thinner placentas. <b>Conclusions:</b> Augmented placental thickness correlates with an elevated cumulative load of fetal dysfunction, especially in the realms of extracardiac and functional cardiac impairments. The measurement of placental thickness may function as a straightforward, supplementary indicator of fetal distress in the third trimester, particularly when utilized alongside targeted imaging modalities.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Murlewska</LastName><ForeName>Julia</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-8266-4585</Identifier><AffiliationInfo><Affiliation>Department of Prenatal Cardiology, Polish Mother's Memorial Hospital Research Institute, Rzgowska 281/289, 93-338 Lodz, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sylwestrzak</LastName><ForeName>Oskar</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Prenatal Cardiology, Polish Mother's Memorial Hospital Research Institute, Rzgowska 281/289, 93-338 Lodz, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Polish Mother's Memorial Hospital Research Institute, 93-338 Lodz, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strzelecka</LastName><ForeName>Iwona</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0003-3469-7064</Identifier><AffiliationInfo><Affiliation>Department of Prenatal Cardiology, Polish Mother's Memorial Hospital Research Institute, Rzgowska 281/289, 93-338 Lodz, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Public Health, Department for Fetal Malformations Diagnoses &amp; Prevention, Medical University of Lodz, 90-419 Lodz, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soko&#x142;owski</LastName><ForeName>&#x141;ukasz</ForeName><Initials>&#x141;</Initials><AffiliationInfo><Affiliation>Department of Prenatal Cardiology, Polish Mother's Memorial Hospital Research Institute, Rzgowska 281/289, 93-338 Lodz, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Polish Mother's Memorial Hospital Research Institute, 93-338 Lodz, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kordjalik</LastName><ForeName>Paulina</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Prenatal Cardiology, Polish Mother's Memorial Hospital Research Institute, Rzgowska 281/289, 93-338 Lodz, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#x142;odki</LastName><ForeName>Maciej</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-0160-8013</Identifier><AffiliationInfo><Affiliation>Department of Prenatal Cardiology, Polish Mother's Memorial Hospital Research Institute, Rzgowska 281/289, 93-338 Lodz, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Health Sciences, The Masovian State University, 09-400 Plock, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Respondek-Liberska</LastName><ForeName>Maria</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-0238-2172</Identifier><AffiliationInfo><Affiliation>Department of Prenatal Cardiology, Polish Mother's Memorial Hospital Research Institute, Rzgowska 281/289, 93-338 Lodz, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Public Health, Department for Fetal Malformations Diagnoses &amp; Prevention, Medical University of Lodz, 90-419 Lodz, Poland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>None</GrantID><Agency>Polish Mother's Research Institute</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>10</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">fetal echocardiography</Keyword><Keyword MajorTopicYN="N">placental thickness</Keyword><Keyword MajorTopicYN="N">prenatal ultrasound</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>9</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>10</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>11</Month><Day>13</Day><Hour>6</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>11</Month><Day>13</Day><Hour>6</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>11</Month><Day>13</Day><Hour>1</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>10</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">41226855</ArticleId><ArticleId IdType="doi">10.3390/jcm14217461</ArticleId><ArticleId IdType="pii">jcm14217461</ArticleId><ArticleId IdType="pmc">PMC12609973</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hu C., Yan Y., Ji F., Zhou H. Maternal Obesity Increases Oxidative Stress in Placenta and It Is Associated With Intestinal Microbiota. Front. Cell Infect. Microbiol. 2021;11:671347. doi: 10.3389/fcimb.2021.671347.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.671347</ArticleId><ArticleId IdType="pmc">PMC8420882</ArticleId><ArticleId IdType="pubmed">34497775</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosado-Y&#xe9;pez P.I., Ch&#xe1;vez-Corral D.V., Reza-L&#xf3;pez S.A., Leal-Berumen I., Fierro-Murga R., Caballero-Cummings S., Levario-Carrillo M. Relation between pregestational obesity and characteristics of the placenta. J. Matern. Fetal Neonatal Med. 2020;33:3425&#x2013;3430. doi: 10.1080/14767058.2019.1573222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14767058.2019.1573222</ArticleId><ArticleId IdType="pubmed">30704317</ArticleId></ArticleIdList></Reference><Reference><Citation>Bianchi C., Taricco E., Cardellicchio M., Mand&#xf2; C., Massari M., Savasi V., Cetin I. The role of obesity and gestational diabetes on placental size and fetal oxygenation. Placenta. 2021;103:59&#x2013;63. doi: 10.1016/j.placenta.2020.10.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.placenta.2020.10.013</ArticleId><ArticleId IdType="pubmed">33080447</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu C., Yang Y., Li J., Wang H., Cheng C., Yang L., Li Q., Deng J., Liang Z., Yin Y., et al. Maternal Diet-Induced Obesity Compromises Oxidative Stress Status and Angiogenesis in the Porcine Placenta by Upregulating Nox2 Expression. Oxid. Med. Cell Longev. 2019;2019:2481592. doi: 10.1155/2019/2481592.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/2481592</ArticleId><ArticleId IdType="pmc">PMC6791269</ArticleId><ArticleId IdType="pubmed">31662816</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashfaq M., Janjua M.Z., Channa M.A. Effect of gestational diabetes and maternal hypertension on gross morphology of placenta. J. Ayub Med. Coll. Abbottabad. 2005;17:44&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">15929527</ArticleId></ArticleIdList></Reference><Reference><Citation>Berceanu C., Tetileanu A.V., Ofi&#x163;eru A.M., Br&#x103;til&#x103; E., Mehedin&#x163;u C., Voicu N.L., Szasz F.A., Berceanu S., Vl&#x103;d&#x103;reanu S., Navolan D.B. Morphological and ultrasound findings in the placenta of diabetic pregnancy. Rom. J. Morphol. Embryol. 2018;59:175&#x2013;186.</Citation><ArticleIdList><ArticleId IdType="pubmed">29940626</ArticleId></ArticleIdList></Reference><Reference><Citation>Miwa I., Sase M., Torii M., Sanai H., Nakamura Y., Ueda K. A thick placenta: A predictor of adverse pregnancy outcomes. Springerplus. 2014;3:353. doi: 10.1186/2193-1801-3-353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2193-1801-3-353</ArticleId><ArticleId IdType="pmc">PMC4112033</ArticleId><ArticleId IdType="pubmed">25077064</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris R.D., Cho C., Wells W.A. Sonography of the placenta with emphasis on pathological correlation. Semin. Ultrasound CT MR. 1996;17:66&#x2013;89. doi: 10.1016/S0887-2171(96)90045-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0887-2171(96)90045-1</ArticleId><ArticleId IdType="pubmed">8845194</ArticleId></ArticleIdList></Reference><Reference><Citation>Murlewska J., Sylwestrzak O., Strzelecka I., Respondek-Liberska M. Maternal urogenital infection and fetal heart functional assessment-what is the missing link? J. Perinat. Med. 2022;51:311&#x2013;316. doi: 10.1515/jpm-2022-0076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/jpm-2022-0076</ArticleId><ArticleId IdType="pubmed">35947453</ArticleId></ArticleIdList></Reference><Reference><Citation>Hohlfeld P., MacAleese J., Capella-Pavlovski M., Giovangrandi Y., Thulliez P., Forestier F., Daffos F. Fetal toxoplasmosis: Ultrasonographic signs. Ultrasound Obstet. Gynecol. 1991;1:241&#x2013;244. doi: 10.1046/j.1469-0705.1991.01040241.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1469-0705.1991.01040241.x</ArticleId><ArticleId IdType="pubmed">12797051</ArticleId></ArticleIdList></Reference><Reference><Citation>Brock M.F., Miranda A.E., B&#xf4;tto-Menezes C., Le&#xe3;o J.R., Martinez-Espinosa F.E. Ultrasound findings in pregnant women with uncomplicated vivax malaria in the Brazilian Amazon: A cohort study. Malar. J. 2015;14:144. doi: 10.1186/s12936-015-0627-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12936-015-0627-1</ArticleId><ArticleId IdType="pmc">PMC4393585</ArticleId><ArticleId IdType="pubmed">25889425</ArticleId></ArticleIdList></Reference><Reference><Citation>Kittipornpechdee N., Hanamornroongruang S., Lekmak D., Treetipsatit J. Fetal and Placental Pathology in Congenital Syphilis: A Comprehensive Study in Perinatal Autopsy. Fetal Pediatr. Pathol. 2018;37:231&#x2013;242. doi: 10.1080/15513815.2018.1485798.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15513815.2018.1485798</ArticleId><ArticleId IdType="pubmed">30207805</ArticleId></ArticleIdList></Reference><Reference><Citation>Krekora M., Zych-Krekora K., S&#x142;odki M., Grzesiak M., Respondek-Liberska M. The course of pregnancy and delivery in a patient with malaria. Ginekol. Pol. 2017;88:574&#x2013;575. doi: 10.5603/GP.a2017.0103.</Citation><ArticleIdList><ArticleId IdType="doi">10.5603/GP.a2017.0103</ArticleId><ArticleId IdType="pubmed">29192419</ArticleId></ArticleIdList></Reference><Reference><Citation>Rawal S., Ray S., Sharma N. Correlation Between Ultrasonographic Placental Thickness and Adverse Fetal and Neonatal Outcomes. Cureus. 2024;16:e56410. doi: 10.7759/cureus.56410.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.56410</ArticleId><ArticleId IdType="pmc">PMC11023942</ArticleId><ArticleId IdType="pubmed">38638712</ArticleId></ArticleIdList></Reference><Reference><Citation>Elchalal U., Ezra Y., Levi Y., Bar-Oz B., Yanai N., Intrator O., Nadjari M. Sonographically thick placenta: A marker for increased perinatal risk--a prospective cross-sectional study. Placenta. 2000;21:268&#x2013;272. doi: 10.1053/plac.1999.0466.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/plac.1999.0466</ArticleId><ArticleId IdType="pubmed">10736252</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X., Shen J., Wang L. Insights into the role of placenta thickness as a predictive marker of perinatal outcome. J. Int. Med. Res. 2021;49:300060521990969. doi: 10.1177/0300060521990969.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0300060521990969</ArticleId><ArticleId IdType="pmc">PMC7890726</ArticleId><ArticleId IdType="pubmed">33583234</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasuhara J., Garg V. Genetics of congenital heart disease: A narrative review of recent advances and clinical implications. Transl. Pediatr. 2021;10:2366&#x2013;2386. doi: 10.21037/tp-21-297.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/tp-21-297</ArticleId><ArticleId IdType="pmc">PMC8506053</ArticleId><ArticleId IdType="pubmed">34733677</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalisch-Smith J.I., Ved N., Sparrow D.B. Environmental Risk Factors for Congenital Heart Disease. Cold Spring Harb. Perspect. Biol. 2020;12:a037234. doi: 10.1101/cshperspect.a037234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a037234</ArticleId><ArticleId IdType="pmc">PMC7050589</ArticleId><ArticleId IdType="pubmed">31548181</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang T.N., Wu Q.J., Liu Y.S., Lv J.L., Sun H., Chang Q., Liu C.F., Zhao Y.H. Environmental Risk Factors and Congenital Heart Disease: An Umbrella Review of 165 Systematic Reviews and Meta-Analyses With More Than 120 Million Participants. Front. Cardiovasc. Med. 2021;8:640729. doi: 10.3389/fcvm.2021.640729.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.640729</ArticleId><ArticleId IdType="pmc">PMC8006458</ArticleId><ArticleId IdType="pubmed">33791351</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamill N., Romero R., Hassan S., Lee W., Myers S.A., Mittal P., Kusanovic J.P., Balasubramaniam M., Chaiworapongsa T., Vaisbuch E., et al. The fetal cardiovascular response to increased placental vascular impedance to flow determined with 4-dimensional ultrasound using spatiotemporal image correlation and virtual organ computer-aided analysis. Am. J. Obstet. Gynecol. 2013;208:153.e1&#x2013;153.e13. doi: 10.1016/j.ajog.2012.11.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2012.11.043</ArticleId><ArticleId IdType="pmc">PMC4070322</ArticleId><ArticleId IdType="pubmed">23220270</ArticleId></ArticleIdList></Reference><Reference><Citation>Leon R.L., Bitar L., Rajagopalan V., Spong C.Y. Interdependence of placenta and fetal cardiac development. Prenat. Diagn. 2024;44:846&#x2013;855. doi: 10.1002/pd.6572.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pd.6572</ArticleId><ArticleId IdType="pmc">PMC11269166</ArticleId><ArticleId IdType="pubmed">38676696</ArticleId></ArticleIdList></Reference><Reference><Citation>Umapathy A., Clark A., Sehgal A., Karanam V., Rajaraman G., Kalionis B., Jones H.N., James J., Murthi P. Molecular regulators of defective placental and cardiovascular development in fetal growth restriction. Clin. Sci. 2024;138:761&#x2013;775. doi: 10.1042/CS20220428.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20220428</ArticleId><ArticleId IdType="pmc">PMC11193155</ArticleId><ArticleId IdType="pubmed">38904187</ArticleId></ArticleIdList></Reference><Reference><Citation>Camm E.J., Botting K.J., Sferruzzi-Perri A.N. Near to One&#x2019;s Heart: The Intimate Relationship Between the Placenta and Fetal Heart. Front. Physiol. 2018;9:629. doi: 10.3389/fphys.2018.00629.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2018.00629</ArticleId><ArticleId IdType="pmc">PMC6029139</ArticleId><ArticleId IdType="pubmed">29997513</ArticleId></ArticleIdList></Reference><Reference><Citation>Sferruzzi-Perri A.N., Camm E.J. The Programming Power of the Placenta. Front. Physiol. 2016;7:33. doi: 10.3389/fphys.2016.00033.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2016.00033</ArticleId><ArticleId IdType="pmc">PMC4789467</ArticleId><ArticleId IdType="pubmed">27014074</ArticleId></ArticleIdList></Reference><Reference><Citation>Respondek-Liberska M., S&#x142;odki M. Klasyfikacja wad serca w kardiologii prenatalnej w III trymestrze i przed porodem. In: Respondek-Liberska M., editor. Wady Serca P&#x142;odu. PZWL Wydawnictwo Lekarskie; Warszawa, Poland: 2021. pp. 123&#x2013;134.</Citation></Reference><Reference><Citation>Respondek-Liberska M. Cz&#x119;&#x15b;&#x107; Szczeg&#xf3;&#x142;owa [Prenatal Ultrasound/ECHO Diagnostics: Functional Changes in the Fetal Circulatory System. Detailed Part] PZWL Wydawnictwo Lekarskie; Warszawa, Poland: 2019. Diagnostyka prenatalna USG/ECHO: Zmiany czynno&#x15b;ciowe w uk&#x142;adzie kr&#x105;&#x17c;enia p&#x142;odu.</Citation></Reference><Reference><Citation>Respondek-Liberska M. Diagnostyka Prenatalna USG/ECHO cz. 1: Wady Wymagaj&#x105;ce Interwencji Chirurgicznej [Prenatal Ultrasound/ECHO Diagnostics Part 1: Defects Requiring Surgical Intervention] PZWL; Warszawa, Poland: 2016.</Citation></Reference><Reference><Citation>Chang C.S., Hong S.Y., Kim S.Y., Kim Y.M., Sung J.H., Choi S.J., Oh S.Y., Roh C.R., Song J., Huh J., et al. Prevalence of associated extracardiac anomalies in prenatally diagnosed congenital heart diseases. PLoS ONE. 2021;16:e0248894. doi: 10.1371/journal.pone.0248894.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0248894</ArticleId><ArticleId IdType="pmc">PMC7971844</ArticleId><ArticleId IdType="pubmed">33735284</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoddick W.K., Mahony B.S., Callen P.W., Filly R.A. Placental thickness. J. Ultrasound Med. 1985;4:479&#x2013;482. doi: 10.7863/jum.1985.4.9.479.</Citation><ArticleIdList><ArticleId IdType="doi">10.7863/jum.1985.4.9.479</ArticleId><ArticleId IdType="pubmed">3903201</ArticleId></ArticleIdList></Reference><Reference><Citation>Strebeck R., Jensen B., Magann E.F. Thick Placenta in Pregnancy: A Review. Obstet. Gynecol. Surv. 2022;77:547&#x2013;557. doi: 10.1097/OGX.0000000000001051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/OGX.0000000000001051</ArticleId><ArticleId IdType="pubmed">36136077</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee A.J., Bethune M., Hiscock R.J. Placental thickness in the second trimester: A pilot study to determine the normal range. J. Ultrasound Med. 2012;31:213&#x2013;218. doi: 10.7863/jum.2012.31.2.213.</Citation><ArticleIdList><ArticleId IdType="doi">10.7863/jum.2012.31.2.213</ArticleId><ArticleId IdType="pubmed">22298864</ArticleId></ArticleIdList></Reference><Reference><Citation>Strzelecka I., Karuga F.F., Szmyd B., Walter A., Daszkiewicz G., Respondek-Liberska M. Placental thickness in 2D prenatal ultrasonographic examination. Arch. Med. Sci. 2021;19:1768&#x2013;1773. doi: 10.5114/aoms/132778.</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/aoms/132778</ArticleId><ArticleId IdType="pmc">PMC10696956</ArticleId><ArticleId IdType="pubmed">38058720</ArticleId></ArticleIdList></Reference><Reference><Citation>Josowitz R., Ho D.Y., Shankar S., Mondal A., Zavez A., Linn R.L., Tian Z., Gaynor J.W., Rychik J. Congenital Heart Disease Fetuses Have Decreased Mid-Gestational Placental Flow, Placental Malperfusion Defects, and Impaired Growth. JACC Adv. 2025;4:101559. doi: 10.1016/j.jacadv.2024.101559.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacadv.2024.101559</ArticleId><ArticleId IdType="pmc">PMC11786062</ArticleId><ArticleId IdType="pubmed">39898349</ArticleId></ArticleIdList></Reference><Reference><Citation>Rychik J., Goff D., McKay E., Mott A., Tian Z., Licht D.J., Gaynor J.W. Characterization of the Placenta in the Newborn with Congenital Heart Disease: Distinctions Based on Type of Cardiac Malformation. Pediatr. Cardiol. 2018;39:1165&#x2013;1171. doi: 10.1007/s00246-018-1876-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00246-018-1876-x</ArticleId><ArticleId IdType="pmc">PMC6096845</ArticleId><ArticleId IdType="pubmed">29728721</ArticleId></ArticleIdList></Reference><Reference><Citation>Respondek-Liberska M., Murlewska J., Wielgo&#x15b; M., Wieche&#x107; M., Czajkowski K., Preis K., &#x15a;wi&#x105;tkowska-Freund M., Mazela J., Oszukowski P., Krekora M., et al. Recommendation of the Polish Prenatal Cardiology Society on the Regulation of the Polish Ministry of Health concerning competencies in fetal echocardiography (code 013) and fetal cardiology (code 021) Prenat. Cardiol. 2023;13:5&#x2013;13. doi: 10.5114/pcard.2023.138621.</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/pcard.2023.138621</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho J.S., Axt-Fliedner R., Chaoui R., Copel J.A., Cuneo B.F., Goff D., Gordin Kopylov L., Hecher K., Lee W., Moon-Grady A.J., et al. ISUOG Practice Guidelines (updated): Fetal cardiac screening. Ultrasound Obstet. Gynecol. 2023;61:788&#x2013;803. doi: 10.1002/uog.26224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/uog.26224</ArticleId><ArticleId IdType="pubmed">37267096</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalil A., Sotiriadis A., D&#x2019;Antonio F., Da Silva Costa F., Odibo A., Prefumo F., Papageorghiou A.T., Salomon L.J. ISUOG Practice Guidelines: Performance of third-trimester obstetric ultrasound scan. Ultrasound Obstet. Gynecol. 2024;63:131&#x2013;147. doi: 10.1002/uog.27538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/uog.27538</ArticleId><ArticleId IdType="pubmed">38166001</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon-Grady A.J., Donofrio M.T., Gelehrter S., Hornberger L., Kreeger J., Lee W., Michelfelder E., Morris S.A., Peyvandi S., Pinto N.M., et al. Guidelines and Recommendations for Performance of the Fetal Echocardiogram: An Update from the American Society of Echocardiography. J. Am. Soc. Echocardiogr. 2023;36:679&#x2013;723. doi: 10.1016/j.echo.2023.04.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.echo.2023.04.014</ArticleId><ArticleId IdType="pubmed">37227365</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">41226805</PMID><DateCompleted><Year>2025</Year><Month>11</Month><Day>13</Day></DateCompleted><DateRevised><Year>2025</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>21</Issue><PubDate><Year>2025</Year><Month>Nov</Month><Day>05</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Gestational Diabetes Exposed Mesenchymal Stem Cells: Phenotypic Differences Link to Long-Term Health of Offspring.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">10768</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms262110768</ELocationID><Abstract><AbstractText>Mesenchymal stem cells (MSCs) derived from the placenta, fetal membranes, or umbilical cord may be used to study the pathophysiology of gestational diabetes mellitus (GDM). The phenotype of MSCs may reflect fetal programming in response to the maternal milieu of a GDM pregnancy. Altered fetal programming is linked to high rates of obesity and type 2 diabetes mellitus (T2DM) in the offspring of mothers with GDM. This review discusses recent findings characterizing the phenotype of GDM-exposed MSCs (GDM-MSCs) which enhance our understanding of the mechanisms of fetal programming. It also considers how MSCs may be used as markers of long-term offspring health to test the benefit of putative interventions and highlights the need for further translational studies to clearly link the MSC phenotype to clinical parameters and interventions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pandrich</LastName><ForeName>Mark J</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0002-3500-1017</Identifier><AffiliationInfo><Affiliation>Imperial College London, London SW7 2AZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Nishel M</ForeName><Initials>NM</Initials><Identifier Source="ORCID">0000-0002-5694-9915</Identifier><AffiliationInfo><Affiliation>Imperial College London, London SW7 2AZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garcia Perez</LastName><ForeName>Isabel</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0001-8398-0603</Identifier><AffiliationInfo><Affiliation>Imperial College London, London SW7 2AZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>Mark R</ForeName><Initials>MR</Initials><Identifier Source="ORCID">0000-0003-1096-9918</Identifier><AffiliationInfo><Affiliation>Imperial College London, London SW7 2AZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Natasha</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-5130-9679</Identifier><AffiliationInfo><Affiliation>Imperial College London, London SW7 2AZ, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>11</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016640" MajorTopicYN="Y">Diabetes, Gestational</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059630" MajorTopicYN="Y">Mesenchymal Stem Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D047109" MajorTopicYN="N">Fetal Development</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="N">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011297" MajorTopicYN="Y">Prenatal Exposure Delayed Effects</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">developmental origins of disease</Keyword><Keyword MajorTopicYN="N">diabetes in pregnancy</Keyword><Keyword MajorTopicYN="N">gestational diabetes mellitus</Keyword><Keyword MajorTopicYN="N">mesenchymal stem cells</Keyword><Keyword MajorTopicYN="N">mesenchymal stromal cells</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>9</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>10</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>11</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>11</Month><Day>13</Day><Hour>6</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>11</Month><Day>13</Day><Hour>6</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>11</Month><Day>13</Day><Hour>1</Hour><Minute>5</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">41226805</ArticleId><ArticleId IdType="doi">10.3390/ijms262110768</ArticleId><ArticleId IdType="pii">ijms262110768</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">41225654</PMID><DateRevised><Year>2025</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1479-7364</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Nov</Month><Day>12</Day></PubDate></JournalIssue><Title>Human genomics</Title><ISOAbbreviation>Hum Genomics</ISOAbbreviation></Journal><ArticleTitle>Atypical presentations of fetal polycystic kidney disease demonstrates the utility of a genomic autopsy for accurate post-mortem diagnoses.</ArticleTitle><Pagination><StartPage>132</StartPage><MedlinePgn>132</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s40246-025-00844-4</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Prenatal presentation of polycystic kidney disease (PKD), characterized by bilateral renal cysts and enlarged echogenic kidneys on ultrasound, often results in perinatal death. Prenatal manifestations of PKD are generally associated with autosomal recessive PKD, most commonly a result of pathogenic variants in PKHD1, but in rare cases can also be driven by bi-allelic inheritance of pathogenic variants in genes more commonly associated with autosomal dominant PKD such as PKD1. Diagnosing the underlying cause of prenatal PKD can be complicated by atypical histology, and/or a prenatal phenotype that does not align with family history. In this study, five cases of prenatal PKD with atypical or inconclusive features identified during post-mortem investigations underwent trio exome or genome sequencing, termed a genomic autopsy.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Genomic autopsy was able to delineate the genetic basis of prenatal PKD in all five families.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our findings demonstrate the diagnostic utility of a genomic autopsy in providing a genetic diagnosis for fetal PKD cases post-mortem, particularly in atypical presentations. A genetic diagnosis is highly beneficial for future family planning, including the use of reproductive technologies, as well as identifying presymptomatic parents who are likely to develop PKD in the future.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Frank</LastName><ForeName>Mahalia S B</ForeName><Initials>MSB</Initials><AffiliationInfo><Affiliation>Department of Genetics and Molecular Pathology, Centre for Cancer Biology, an alliance between SA Pathology and the University of South Australia, Frome Road, Adelaide, SA, 5000, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>South Australian Health and Medical Research Institute, Adelaide, SA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bennett</LastName><ForeName>Melissa K</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Department of Genetics and Molecular Pathology, Centre for Cancer Biology, an alliance between SA Pathology and the University of South Australia, Frome Road, Adelaide, SA, 5000, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ha</LastName><ForeName>Thuong T</ForeName><Initials>TT</Initials><AffiliationInfo><Affiliation>Department of Genetics and Molecular Pathology, Centre for Cancer Biology, an alliance between SA Pathology and the University of South Australia, Frome Road, Adelaide, SA, 5000, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ACRF Genomics Facility, Centre for Cancer Biology, an alliance between SA Pathology and the University of South Australia, Adelaide, SA, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Adelaide Medical School, University of Adelaide, Adelaide, SA, 5000, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UniSA Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moore</LastName><ForeName>Lynette</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Adelaide Medical School, University of Adelaide, Adelaide, SA, 5000, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anatomical Pathology, SA Pathology, Women's and Children's Hospital, North Adelaide, SA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arts</LastName><ForeName>Peer</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Genetics and Molecular Pathology, Centre for Cancer Biology, an alliance between SA Pathology and the University of South Australia, Frome Road, Adelaide, SA, 5000, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Adelaide Medical School, University of Adelaide, Adelaide, SA, 5000, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Byrne</LastName><ForeName>Alicia B</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>Department of Genetics and Molecular Pathology, Centre for Cancer Biology, an alliance between SA Pathology and the University of South Australia, Frome Road, Adelaide, SA, 5000, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UniSA Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Babic</LastName><ForeName>Milena</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Genetics and Molecular Pathology, Centre for Cancer Biology, an alliance between SA Pathology and the University of South Australia, Frome Road, Adelaide, SA, 5000, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arriola-Martinez</LastName><ForeName>Luis</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Genetics and Molecular Pathology, Centre for Cancer Biology, an alliance between SA Pathology and the University of South Australia, Frome Road, Adelaide, SA, 5000, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ACRF Genomics Facility, Centre for Cancer Biology, an alliance between SA Pathology and the University of South Australia, Adelaide, SA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toubia</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>ACRF Genomics Facility, Centre for Cancer Biology, an alliance between SA Pathology and the University of South Australia, Adelaide, SA, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UniSA Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brautigan</LastName><ForeName>Peter J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>Department of Genetics and Molecular Pathology, Centre for Cancer Biology, an alliance between SA Pathology and the University of South Australia, Frome Road, Adelaide, SA, 5000, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UniSA Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Jinghua</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>ACRF Genomics Facility, Centre for Cancer Biology, an alliance between SA Pathology and the University of South Australia, Adelaide, SA, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UniSA Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schwarz</LastName><ForeName>Quenten</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Genetics and Molecular Pathology, Centre for Cancer Biology, an alliance between SA Pathology and the University of South Australia, Frome Road, Adelaide, SA, 5000, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UniSA Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>Paul Q</ForeName><Initials>PQ</Initials><AffiliationInfo><Affiliation>Robinson Research Institute, School of Biomedicine, The University of Adelaide, Adelaide, SA, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>South Australian Health and Medical Research Institute, Adelaide, SA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piltz</LastName><ForeName>Sandra G</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>Robinson Research Institute, School of Biomedicine, The University of Adelaide, Adelaide, SA, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>South Australian Health and Medical Research Institute, Adelaide, SA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>White</LastName><ForeName>Melissa A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Robinson Research Institute, School of Biomedicine, The University of Adelaide, Adelaide, SA, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>South Australian Health and Medical Research Institute, Adelaide, SA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moghimi</LastName><ForeName>Ali</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>The Children's Hospital at Westmead Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Histopathology, The Children's Hospital at Westmead, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strachan</LastName><ForeName>Kate</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Anatomical Pathology, Royal Women's Hospital (A Division of Royal Children's Hospital Laboratory Services), Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwan</LastName><ForeName>Edward</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Pathology, Monash Health, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Springer</LastName><ForeName>Amanda</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Paediatrics, Monash University, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Australian Institute of Health Innovation, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lewit-Mendes</LastName><ForeName>Miranda</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Monash Genetics, Monash Health, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Paediatrics, University of Melbourne, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dearman</LastName><ForeName>Jarrad</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Paediatric and Reproductive Genetics Unit, South Australian Clinical Genetics Service, Women's and Children's Hospital, North Adelaide, SA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davis</LastName><ForeName>Tenielle</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Royal Women's Hospital, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kevin</LastName><ForeName>Lucy</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Clinical Genetics, Sydney Children's Hospitals Network-Westmead, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCarthy</LastName><ForeName>Hugh J</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>KidGen Collaborative, Australian Genomics Health Alliance, Parkville, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Discipline of Child and Adolescent Health, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Kidney Research, Kids Research Institute and the Department of Nephrology, The Children's Hospital at Westmead, Westmead, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liebelt</LastName><ForeName>Jan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Adelaide Medical School, University of Adelaide, Adelaide, SA, 5000, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Paediatric and Reproductive Genetics Unit, South Australian Clinical Genetics Service, Women's and Children's Hospital, North Adelaide, SA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krzesinski</LastName><ForeName>Emma</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Paediatrics, Monash University, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Monash Genetics, Monash Health, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Regan</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Paediatrics, Monash University, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Monash Genetics, Monash Health, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verma</LastName><ForeName>Kunal</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Monash Genetics, Monash Health, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McGillivray</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Victorian Clinical Genetics Services, Murdoch Children's Research Institute and Royal Women's Hospital, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jayasinghe</LastName><ForeName>Kushani</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Monash Health, Clayton, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Monash University, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jackson</LastName><ForeName>Matilda R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Department of Genetics and Molecular Pathology, Centre for Cancer Biology, an alliance between SA Pathology and the University of South Australia, Frome Road, Adelaide, SA, 5000, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Australian Genomics, Parkville, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barnett</LastName><ForeName>Christopher P</ForeName><Initials>CP</Initials><AffiliationInfo><Affiliation>Adelaide Medical School, University of Adelaide, Adelaide, SA, 5000, Australia. christopher.barnett@sa.gov.au.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Paediatric and Reproductive Genetics Unit, South Australian Clinical Genetics Service, Women's and Children's Hospital, North Adelaide, SA, Australia. christopher.barnett@sa.gov.au.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scott</LastName><ForeName>Hamish S</ForeName><Initials>HS</Initials><Identifier Source="ORCID">0000-0002-5813-631X</Identifier><AffiliationInfo><Affiliation>Department of Genetics and Molecular Pathology, Centre for Cancer Biology, an alliance between SA Pathology and the University of South Australia, Frome Road, Adelaide, SA, 5000, Australia. hamish.scott@sa.gov.au.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ACRF Genomics Facility, Centre for Cancer Biology, an alliance between SA Pathology and the University of South Australia, Adelaide, SA, Australia. hamish.scott@sa.gov.au.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Adelaide Medical School, University of Adelaide, Adelaide, SA, 5000, Australia. hamish.scott@sa.gov.au.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UniSA Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia. hamish.scott@sa.gov.au.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Australian Genomics, Parkville, VIC, Australia. hamish.scott@sa.gov.au.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>APP2021396</GrantID><Agency>National Health and Medical Research Council</Agency><Country/></Grant><Grant><GrantID>APP2023357</GrantID><Agency>Medical Research Futures Fund Early to Mid-Career Researchers Grant Opportunity</Agency><Country/></Grant><Grant><GrantID>GHFM76777</GrantID><Agency>Genomics Health Futures Mission - Medical Research Futures Fund</Agency><Country/></Grant><Grant><GrantID>GNT1113531</GrantID><Agency>Australian Genomics Health Alliance NHMRC, Targeted Call for Research into Preparing Australia for the Genomics Revolution in Healthcare</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>11</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Hum Genomics</MedlineTA><NlmUniqueID>101202210</NlmUniqueID><ISSNLinking>1473-9542</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ADPKD</Keyword><Keyword MajorTopicYN="N">ARPKD</Keyword><Keyword MajorTopicYN="N">Genomics</Keyword><Keyword MajorTopicYN="N">Polycystic kidney disease</Keyword><Keyword MajorTopicYN="N">Pregnancy loss</Keyword><Keyword MajorTopicYN="N">Prenatal</Keyword></KeywordList><CoiStatement>Declarations. Ethics approval and consent to participate: This study was performed as part of the NHMRC- and GHFM-MRFF-funded Australian Genomic Autopsy Study and was approved by the Human Ethics Committee of the Women&#x2019;s and Children&#x2019;s Health Network, South Australia, Australia (HREC/15/WCHN/35) and Melbourne Health as part of the Australian Genomics Health Alliance protocol (HREC/16/MH/251). This study was conducted in accordance with the Declaration of Helsinki. Details on consent and data storage have been previously published for this cohort [25]. Animal ethics for the Tmem212 knockout mouse model was approved by the Central Adelaide Local Health Network Animal Ethics Committee, South Australia, Australia (48a/14), and research was conducted in accordance with the Australian code for the care and use of animals for scientific purposes. Consent for publication: Consent for publication was provided by all families as part of the Genomic Autopsy Study consent forms. Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>9</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>10</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>11</Month><Day>13</Day><Hour>6</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>11</Month><Day>13</Day><Hour>6</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>11</Month><Day>13</Day><Hour>0</Hour><Minute>5</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">41225654</ArticleId><ArticleId IdType="doi">10.1186/s40246-025-00844-4</ArticleId><ArticleId IdType="pii">10.1186/s40246-025-00844-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bergmann C, Guay-Woodford LM, Harris PC, Horie S, Peters DJM, Torres VE. Polycystic kidney disease. Nat Rev Dis Primers. 2018;4(50).</Citation></Reference><Reference><Citation>Goggolidou P, Richards T. The genetics of autosomal recessive polycystic kidney disease (ARPKD). Biochimica et Biophysica Acta (BBA). 2022;1868:166348.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2022.166348</ArticleId></ArticleIdList></Reference><Reference><Citation>Orr S, Sayer JA. Many lessons still to learn about autosomal dominant polycystic kidney disease. J Rare Dis (Berlin). 2023;2(13).</Citation></Reference><Reference><Citation>Reiterov&#xe1; J, Tesa&#x159; V. Autosomal Dominant Polycystic Kidney Disease: From Pathophysiology of Cystogenesis to Advances in the Treatment. Int J Mol Sci. 2022;23.</Citation></Reference><Reference><Citation>Hopp K, Ward CJ, Hommerding CJ, Nasr SH, Tuan HF, Gainullin VG, et al. Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity. J Clin Invest. 2012;122. https://doi.org/10.1172/JCI64313</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI64313</ArticleId><ArticleId IdType="pubmed">23064367</ArticleId><ArticleId IdType="pmc">3484456</ArticleId></ArticleIdList></Reference><Reference><Citation>Lakhia R, Ramalingam H, Chang CM, Cobo-Stark P, Biggers L, Flaten A, et al. PKD1 and PKD2 mRNA cis-inhibition drives polycystic kidney disease progression. Nat Commun. 2022;13. https://doi.org/10.1038/s41467-022-32543-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-32543-2</ArticleId><ArticleId IdType="pubmed">35965273</ArticleId><ArticleId IdType="pmc">9376183</ArticleId></ArticleIdList></Reference><Reference><Citation>Landrum MJ, Lee JM, Riley GR, Jang W, Rubinstein WS, Church DM. ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res. 2014;42(1):980&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkt1113</ArticleId></ArticleIdList></Reference><Reference><Citation>Devuyst O, Ahn C, Barten TRM, Brosnahan G, Cadnapaphornchai MA, Chapman AB, Cornec-Le Gall E, Drenth JPH, Gansevoort RT, Harris PC, Harris T, Horie S, Liebau MC, Liew M, Mallett AJ, Mei C, Mekahli D, Odland D, Ong ACM, Onuchic LF, Pei YP-C, Perrone RD, Rangan GK, Rayner B, Torra R, Mustafa R, Torres VE. KDIGO 2025 Clinical Practice Guideline for the Evaluation, Management, and Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD). Kidney Int. 2025;107(2):S1-S239.</Citation></Reference><Reference><Citation>Rehm HL, Berg JS, Brooks LD, Bustamante CD, Evans JP, Landrum MJ, et al. ClinGen the clinical genome resource. N Engl J Med. 2015;372:2235&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMsr1406261</ArticleId><ArticleId IdType="pubmed">26014595</ArticleId><ArticleId IdType="pmc">4474187</ArticleId></ArticleIdList></Reference><Reference><Citation>Cornec-Le Gall E, Olson RJ, Besse W, Heyer CM, Gainullin VG, Smith JM, Audr&#xe9;zet MP, Hopp K, Porath B, Shi B, Baheti S, Senum SR, Arroyo J, Madsen CD, F&#xe9;rec C, Joly D, Jouret F, Fikri-Benbrahim O, Charasse C, Coulibaly JM, Yu AS, Khalili K, Pei Y, Somlo S, Le Meur Y, Torres VE; Genkyst Study Group; HALT Progression of Polycystic Kidney Disease Group; Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease; Harris PC. Monoallelic Mutations to DNAJB11 Cause Atypical Autosomal-Dominant Polycystic Kidney Disease. Am J Hum Genet. 2018;102(5).</Citation></Reference><Reference><Citation>Jawaid T, Elbarougy DE, Lavu S, Buia G, Senum SR, Olinger E, Yang H, McDonnell SK, Bublitz JT, Ma J, Audr&#xe9;zet MP, Madsen CD, Schauer RS, Baker TA, Gregory AV, Orr SG, Barroso-Gil M, Neatu R, Joli G, Dahl NK, Kline TL, Gillion V, Dahan K, Jouret F, Perrone RD, Steinman TI, Peters DJM, Gitomer BY, Watnick TJ, Coto E, Chebib FT, Hogan MC, Olson JE, Larson NB, Ars E, Halbritter J, Demoulin N, Torres VE, Sayer JA, Cornec-Le Gall E, Harris PC; Genomics England Research Consortium, UK Biobank, HALT PKD, DIPAK, TAME PKD, Genkyst studies, Mayo Clinic Biobank, and Regeneron Genetics Center. Characterization of the Cystic Phenotype Associated with Monoallelic ALG8 and ALG9 Pathogenic Variants. J Am Soc Nephrol. 2025;Epub ahead of print.</Citation></Reference><Reference><Citation>Lanktree MB, Haghighi A, di Bari I, Song X, Pei Y. Insights into autosomal dominant polycystic kidney disease from genetic studies. Clin J Am Soc Nephrol. 2021;16(5):790&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.02320220</ArticleId><ArticleId IdType="pubmed">32690722</ArticleId><ArticleId IdType="pmc">8259493</ArticleId></ArticleIdList></Reference><Reference><Citation>Senum SR, Li YSM, Benson KA, Joli G, Olinger E, Lavu S, Madsen CD, Gregory AV, Neatu R, Kline TL, Audr&#xe9;zet MP, Outeda P, Nau CB, Meijer E, Ali H, Steinman TI, Mrug M, Phelan PJ, Watnick TJ, Peters DJM, Ong ACM, Conlon PJ, Perrone RD, Cornec-Le Gall E, Hogan MC, Torres VE, Sayer JA; Genomics England Research Consortium, the HALT PKD, CRISP, DIPAK, ADPKD Modifier, and TAME PKD studies; Harris PC. Monoallelic IFT140 pathogenic variants are an important cause of the autosomal dominant polycystic kidney-spectrum phenotype. Am J Hum Genet. 2022;109(1):136&#x2013;56.</Citation></Reference><Reference><Citation>Sweeney WEJ, Avner ED. Pathophysiology of childhood polycystic kidney diseases: new insights into disease-specific therapy. Pediatr Res. 2014;75 . https://doi.org/10.1038/pr.2013.191</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/pr.2013.191</ArticleId><ArticleId IdType="pubmed">24336431</ArticleId></ArticleIdList></Reference><Reference><Citation>Cordido A, Vizoso-Gonzalez M, Garcia-Gonzalez MA. Molecular pathophysiology of autosomal recessive polycystic kidney disease. Int J Mol Sci. 2021;22 . https://doi.org/10.3390/ijms22126523</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22126523</ArticleId><ArticleId IdType="pubmed">34204582</ArticleId><ArticleId IdType="pmc">8235086</ArticleId></ArticleIdList></Reference><Reference><Citation>Wehrman A, Kriegermeier A, Wen J. Diagnosis and management of hepatobiliary complications in autosomal recessive polycystic kidney disease. Front Pediatr. 2017;5. https://doi.org/10.3389/fped.2017.00124</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2017.00124</ArticleId><ArticleId IdType="pubmed">28611971</ArticleId><ArticleId IdType="pmc">5446979</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu H, Galeano MCR, Ott E, Kaeslin G, Kausalya PJ, Kramer C, et al. Mutations in DZIP1L, which encodes a ciliary-transition-zone protein, cause autosomal recessive polycystic kidney disease. Nat Genet. 2017;49(7):1025&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3871</ArticleId><ArticleId IdType="pubmed">28530676</ArticleId><ArticleId IdType="pmc">5687889</ArticleId></ArticleIdList></Reference><Reference><Citation>Vujic M, Heyer CM, Ars E, Hopp K, Markoff A, Orndal C, et al. Incompletely penetrant PKD1 alleles mimic the renal manifestations of ARPKD. J Am Soc Nephrol. 2010;21(7):1097&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2009101070</ArticleId><ArticleId IdType="pubmed">20558538</ArticleId><ArticleId IdType="pmc">3152226</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilbert RD, Sukhtankar P, Lachlan K, Fowler DJ. Bilineal inheritance of PKD1 abnormalities mimicking autosomal recessive polycystic disease. Pediatr Nephrol. 2013;28. https://doi.org/10.1007/s00467-013-2484-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00467-013-2484-x</ArticleId><ArticleId IdType="pubmed">24317637</ArticleId></ArticleIdList></Reference><Reference><Citation>Losekoot M, Ruivenkamp CA, Tholens AP, Grimbergen JE, Vijfhuizen L, Vermeer S, et al. Neonatal onset autosomal dominant polycystic kidney disease (ADPKD) in a patient homozygous for a PKD2 missense mutation due to uniparental disomy. J Med Genet. 2012;49(1):37&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jmedgenet-2011-100452</ArticleId><ArticleId IdType="pubmed">22114106</ArticleId></ArticleIdList></Reference><Reference><Citation>Ate&#x15f; EA, Turkyilmaz A, Delil K, Alavanda C, S&#xf6;ylemez MA, Ge&#xe7;kinli BB, et al. Biallelic mutations in DNAJB11 are associated with prenatal polycystic kidney disease in a Turkish family. Mol Syndromol. 2021;12. https://doi.org/10.1159/000513611</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000513611</ArticleId><ArticleId IdType="pubmed">34177435</ArticleId><ArticleId IdType="pmc">8216001</ArticleId></ArticleIdList></Reference><Reference><Citation>Jordan P, Arrondel C, Bessi&#xe8;res B, Tessier A, Atti&#xe9;-Bitach T, Guterman S, et al. Bi-allelic pathogenic variations in DNAJB11 cause Ivemark II syndrome, a renal-hepatic-pancreatic dysplasia. Kidney Int. 2021;99. https://doi.org/10.1016/j.kint.2020.09.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2020.09.029</ArticleId><ArticleId IdType="pubmed">33836171</ArticleId><ArticleId IdType="pmc">8319106</ArticleId></ArticleIdList></Reference><Reference><Citation>Saini N, Venkatapuram VS, Vineeth VS, Kulkarni A, Tandon A, Koppolu G, et al. Fetal phenotypes of Mendelian disorders: a descriptive study from India. Prenat Diagn. 2022;42(7):911&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pd.6172</ArticleId><ArticleId IdType="pubmed">35587316</ArticleId></ArticleIdList></Reference><Reference><Citation>Lefebvre M, Bruel AL, Tisserant E, Bourgon N, Duffourd Y, Collardeau-Frachon S, et al. Genotype-first in a cohort of 95 fetuses with multiple congenital abnormalities: when exome sequencing reveals unexpected fetal phenotype-genotype correlations. J Med Genet. 2021;58(6):400&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jmedgenet-2020-106867</ArticleId><ArticleId IdType="pubmed">32732226</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne AB, Arts P, Ha TT, Kassahn KS, Pais LS, O'Donnell-Luria A; Broad Institute Center for Mendelian Genomics; Babic M, Frank MSB, Feng J, Wang P, Lawrence DM, Eshraghi L, Arriola L, Toubia J, Nguyen H; Genomic Autopsy Study Research Network; McGillivray G, Pinner J, McKenzie F, Morrow R, Lipsett J, Manton N, Khong TY, Moore L, Liebelt JE, Schreiber AW, King-Smith SL, Hardy TSE, Jackson MR, Barnett CP, Scott HS. Genomic autopsy to identify underlying causes of pregnancy loss and perinatal death. Nat Med. 2023;29(1).</Citation></Reference><Reference><Citation>Ryan D, Sutherland MR, Flores TJ, Kent AL, Dahlstrom JE, Puelles VG, et al. Development of the human fetal kidney from mid to late gestation in male and female infants. EBioMedicine. 2018;27:275&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2017.12.016</ArticleId><ArticleId IdType="pubmed">29329932</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryen SJ, Yuen M, Joshi H, Dawes R, Zhang K, Lu JK, et al. Prevalence, parameters, and pathogenic mechanisms for splice-altering acceptor variants that disrupt the AG exclusion zone. HGG Adv. 2022;3(4):100125.</Citation><ArticleIdList><ArticleId IdType="pubmed">35847480</ArticleId><ArticleId IdType="pmc">9284458</ArticleId></ArticleIdList></Reference><Reference><Citation>Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17 . https://doi.org/10.1038/gim.2015.30</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gim.2015.30</ArticleId><ArticleId IdType="pubmed">25834946</ArticleId><ArticleId IdType="pmc">4544753</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical Genomics Resource. Available from: https://search.clinicalgenome.org/CCID:004676 .</Citation></Reference><Reference><Citation>Ambrosini E, Montanari F, Cristalli CP, Capelli I, La Scola C, Pasini A, et al. Modifiers of autosomal dominant polycystic kidney disease severity: the role of PKD1 hypomorphic alleles. Genes. 2023;14. https://doi.org/10.3390/genes14061230</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes14061230</ArticleId><ArticleId IdType="pubmed">37372421</ArticleId><ArticleId IdType="pmc">10297877</ArticleId></ArticleIdList></Reference><Reference><Citation>Jayasinghe K, Stark Z, Kerr PG, Gaff C, Martyn M, Whitlam J, et al. Clinical impact of genomic testing in patients with suspected monogenic kidney disease. Genet Med. 2021;23(1):183&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41436-020-00963-4</ArticleId><ArticleId IdType="pubmed">32939031</ArticleId></ArticleIdList></Reference><Reference><Citation>Durkie M, Chong J, Valluru MK, Harris PC, Ong ACM. Biallelic inheritance of hypomorphic PKD1 variants is highly prevalent in very early onset polycystic kidney disease. Genet Med. 2021;23. https://doi.org/10.1038/s41436-020-01026-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41436-020-01026-4</ArticleId><ArticleId IdType="pubmed">34906457</ArticleId><ArticleId IdType="pmc">8553612</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossetti S, Kubly VJ, Consugar MB, Hopp K, Roy S, Horsley SW, Chauveau D, Rees L, Barratt TM, van't Hoff WG, Niaudet P, Torres VE, Harris PC. Incompletely penetrant PKD1 alleles suggest a role for gene dosage in cyst initiation in polycystic kidney disease. Kidney Int. 2009;75(8).</Citation></Reference><Reference><Citation>Zheng Y, Wong L, Kwan AHW, Dong Z, Kwok KY, Choy KW, et al. Prenatal diagnosis of polycystic kidney caused by biallelic hypomorphic variants in the PKD1 gene. Prenat Diagn. 2024;44. https://doi.org/10.1002/pd.6419</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pd.6419</ArticleId><ArticleId IdType="pubmed">39702865</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris PC, Torres VE. Polycystic Kidney Disease, Autosomal Dominant. In: Adam MP, Feldman J, Mirzaa GM, et al., editor. GeneReviews. Seattle (WA): University of Washington; 2022.</Citation></Reference><Reference><Citation>Claus LR, Chen C, Stallworth J, Turner JL, Slaats GG, Hawks AL, et al. Certain heterozygous variants in the kinase domain of the serine/threonine kinase NEK8 can cause an autosomal dominant form of polycystic kidney disease. Kidney Int. 2023;104(5):995&#x2013;1007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2023.07.021</ArticleId><ArticleId IdType="pubmed">37598857</ArticleId><ArticleId IdType="pmc">10592035</ArticleId></ArticleIdList></Reference><Reference><Citation>Apple B, Sartori G, Moore B, Chintam K, Singh G, Anand PM, et al. Individuals heterozygous for ALG8 protein-truncating variants are at increased risk of a mild cystic kidney disease. Kidney Int. 2023;103(3):607&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2022.11.025</ArticleId><ArticleId IdType="pubmed">36574950</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">41225594</PMID><DateCompleted><Year>2025</Year><Month>11</Month><Day>13</Day></DateCompleted><DateRevised><Year>2025</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1479-7364</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Nov</Month><Day>12</Day></PubDate></JournalIssue><Title>Human genomics</Title><ISOAbbreviation>Hum Genomics</ISOAbbreviation></Journal><ArticleTitle>Fetal fractions mediate the association between total cell-free DNA and preeclampsia risk in a non-invasive prenatal testing cohort.</ArticleTitle><Pagination><StartPage>133</StartPage><MedlinePgn>133</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s40246-025-00856-0</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Non-invasive prenatal testing (NIPT)-derived total cell-free DNA (cfDNA) and fetal fractions (FFs) are potential indicators of placental dysfunction, a hallmark of preeclampsia (PE). However, their clinical utility in PE risk stratification, particularly in twin pregnancies, remains underexplored. This study evaluated the association between total cfDNA levels and the incidence of PE and assessed mediation by FFs.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This retrospective cohort study included 2,366 pregnant women who underwent NIPT at 12-22 weeks of gestation at a tertiary hospital. Total cfDNA levels and FFs were extracted from the NIPT data, and PE diagnoses were confirmed via medical records. Logistic regression and mediation analyses were used to assess associations and mediating effects.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">PE prevalence was 3.51% (83/2,366). Elevated total cfDNA tertiles (T2/T3 vs. T1) were associated with increased rates of PE (T2: OR&#x2009;=&#x2009;2.36, 95% CI: 1.16-4.80; T3: OR&#x2009;=&#x2009;3.00, 95% CI: 1.51-5.97). Each 1&#xa0;&#xb5;g/L increase in total cfDNA was associated with a 12% increase in PE odds (OR&#x2009;=&#x2009;1.12, 95% CI: 1.05-1.20). Lower FFs were associated with PE risk (T1 vs. T3: OR&#x2009;=&#x2009;2.70, 95% CI: 1.45-5.00; per 1% decrease: OR&#x2009;=&#x2009;1.15, 95% CI: 1.07-1.23). In singleton pregnancies, total cfDNA levels&#x2009;&#x2264;&#x2009;4.41&#xa0;&#xb5;g/L were significantly associated with increased PE risk (OR&#x2009;=&#x2009;2.89, 95% CI: 1.32-6.29, P&#x2009;=&#x2009;0.008) with a validated threshold effect [log-likelihood ratio test (LRT, P&#x2009;=&#x2009;0.005)], while FF&#x2009;&#x2264;&#x2009;8.86% showed a protective trend (OR&#x2009;=&#x2009;0.81, 95% CI: 0.68-0.97, P&#x2009;=&#x2009;0.021) despite a nonsignificant LRT (P&#x2009;=&#x2009;0.192). In twin pregnancies, total cfDNA showed no significant threshold or linear association with PE risk (OR&#x2009;=&#x2009;1.06, P&#x2009;=&#x2009;0.382; LRT, P&#x2009;=&#x2009;0.215), while FFs exhibited a stronger inverse linear association (OR&#x2009;=&#x2009;0.77, 95% CI: 0.65-0.92, P&#x2009;=&#x2009;0.003) with no significant threshold effect (LRT, P&#x2009;=&#x2009;0.270). Total cfDNA was inversely correlated with FFs (T3 vs. T1: &#x3b2;=-2.96, 95% CI: -3.34 to -2.59). Mediation analyses showed FFs partially explained 24.4% and 32.5% of the total cfDNA-PE relationship in singleton pregnancies and all pregnancies, respectively.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This study observed that elevated total cfDNA levels during NIPT were associated with an increased risk of PE, with FFs acting as partial mediators. These findings warrant further investigation into total cfDNA and FFs as potential biomarkers for early PE risk stratification, even in high-risk settings such as twin pregnancies, to determine whether their use in screening could contribute to the development of strategies aimed at improving maternal-fetal health.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhang</LastName><ForeName>Bin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Medical Genetics, Changzhou Maternal and Child Health Care Hospital, Changzhou Medical Center, Nanjing Medical University, 16th Ding Xiang Road, Changzhou, 213023, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Chen</LastName><ForeName>Xusheng</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Medical Genetics, Changzhou Maternal and Child Health Care Hospital, Changzhou Medical Center, Nanjing Medical University, 16th Ding Xiang Road, Changzhou, 213023, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xi</LastName><ForeName>Sijie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medical Genetics, Changzhou Maternal and Child Health Care Hospital, Changzhou Medical Center, Nanjing Medical University, 16th Ding Xiang Road, Changzhou, 213023, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhan</LastName><ForeName>Zhaolong</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Medical Genetics, Changzhou Maternal and Child Health Care Hospital, Changzhou Medical Center, Nanjing Medical University, 16th Ding Xiang Road, Changzhou, 213023, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>He</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Medical Genetics, Changzhou Maternal and Child Health Care Hospital, Changzhou Medical Center, Nanjing Medical University, 16th Ding Xiang Road, Changzhou, 213023, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yinglu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Medical Genetics, Changzhou Maternal and Child Health Care Hospital, Changzhou Medical Center, Nanjing Medical University, 16th Ding Xiang Road, Changzhou, 213023, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Xiaosong</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Medical Genetics, Changzhou Maternal and Child Health Care Hospital, Changzhou Medical Center, Nanjing Medical University, 16th Ding Xiang Road, Changzhou, 213023, Jiangsu, China. xiaosongyuan@njmu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>ZD202418</GrantID><Agency>Major Science and Technology Project of Changzhou Municipal Health Commission</Agency><Country/></Grant><Grant><GrantID>H2023131</GrantID><Agency>General project of Jiangsu Provincial Health Commission</Agency><Country/></Grant><Grant><GrantID>CM20240013</GrantID><Agency>Changzhou Key Laboratory of Maternal and Child Health Medicine</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>11</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Hum Genomics</MedlineTA><NlmUniqueID>101202210</NlmUniqueID><ISSNLinking>1473-9542</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073888">Cell-Free Nucleic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011225" MajorTopicYN="Y">Pre-Eclampsia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073888" MajorTopicYN="Y">Cell-Free Nucleic Acids</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005333" MajorTopicYN="Y">Fetus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000081182" MajorTopicYN="Y">Noninvasive Prenatal Testing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011296" MajorTopicYN="N">Prenatal Diagnosis</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059285" MajorTopicYN="N">Pregnancy, Twin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cell free DNA</Keyword><Keyword MajorTopicYN="N">Fetal fractions</Keyword><Keyword MajorTopicYN="N">Mediating effect</Keyword><Keyword MajorTopicYN="N">Non-invasive prenatal testing</Keyword><Keyword MajorTopicYN="N">Preeclampsia</Keyword><Keyword MajorTopicYN="N">Twin pregnancies</Keyword></KeywordList><CoiStatement>Declarations. Ethics approval and consent to participate: The study protocol was approved by the Ethical Committee of Changzhou Maternal and Child Health Care Hospital (ZD201803). Owing to the anonymous data recorded in the present study, the requirement for written informed consent was waived by the Ethical Committee of Changzhou Maternal and Child Health Care Hospital. All methods in this study were performed in accordance with relevant guidelines and regulations. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>5</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>10</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>11</Month><Day>13</Day><Hour>6</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>11</Month><Day>13</Day><Hour>6</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>11</Month><Day>13</Day><Hour>0</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">41225594</ArticleId><ArticleId IdType="doi">10.1186/s40246-025-00856-0</ArticleId><ArticleId IdType="pii">10.1186/s40246-025-00856-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Yang Y, Le Ray I, Zhu J, Zhang J, Hua J, Reilly M. Preeclampsia, prevalence. Risk factors, and pregnancy outcomes in Sweden and China. JAMA Netw Open. 2021;4(5):e218401. https://doi.org/10.1001/jamanetworkopen.2021.8401 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.8401</ArticleId><ArticleId IdType="pubmed">33970258</ArticleId><ArticleId IdType="pmc">8111481</ArticleId></ArticleIdList></Reference><Reference><Citation>Mou AD, Barman Z, Hasan M, Miah R, Hafsa JM, Das Trisha A. Prevalence of preeclampsia and the associated risk factors among pregnant women in Bangladesh. Sci Rep. 2021;11(1):21339. https://doi.org/10.1038/s41598-021-00839-w .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-00839-w</ArticleId><ArticleId IdType="pubmed">34716385</ArticleId><ArticleId IdType="pmc">8556297</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmiero P, Caretto P, Ciccone MM, Maiello M. Long-term cardiovascular risk and maternal history of pre-eclampsia. J Clin Med. 2025;14(9):3121. https://doi.org/10.3390/jcm14093121 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm14093121</ArticleId><ArticleId IdType="pubmed">40364153</ArticleId><ArticleId IdType="pmc">12072551</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeldt DS, Bird IM. Vascular adaptation in pregnancy and endothelial dysfunction in preeclampsia. J Endocrinol. 2017;232(1):R27&#x2013;44. https://doi.org/10.1530/JOE-16-0340 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/JOE-16-0340</ArticleId><ArticleId IdType="pubmed">27729465</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaemsaithong P, Sahota DS, Poon LC. First trimester preeclampsia screening and prediction. Am J Obstet Gynecol. 2022;226(2S):S1071&#x2013;97. https://doi.org/10.1016/j.ajog.2020.07.020 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2020.07.020</ArticleId><ArticleId IdType="pubmed">32682859</ArticleId></ArticleIdList></Reference><Reference><Citation>Kozlowski S, Zgliczynska M, Kosinska-Kaczynska K. Biomarkers of angiogenesis in twin gestations and the risk of preeclampsia - review of the current literature. Ginekol Pol. 2020;91(12):773&#x2013;6. https://doi.org/10.5603/GP.a2020.0133 .</Citation><ArticleIdList><ArticleId IdType="doi">10.5603/GP.a2020.0133</ArticleId><ArticleId IdType="pubmed">33447998</ArticleId></ArticleIdList></Reference><Reference><Citation>Benk&#x151; Z, Wright A, Rehal A, Cimpoca B, Syngelaki A, Delgado JL. Prediction of pre&#x2010;eclampsia in twin pregnancy by maternal factors and biomarkers at 11&#x2013;13&#x2009;weeks&#x2019; gestation: data from EVENTS trial. Ultrasound Obstet Gynecol. 2021;57(2):257&#x2013;65. https://doi.org/10.1002/uog.23531 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/uog.23531</ArticleId><ArticleId IdType="pubmed">33142361</ArticleId></ArticleIdList></Reference><Reference><Citation>Taglauer ES, Wilkins-Haug L, Bianchi DW. Review: cell-free fetal DNA in the maternal circulation as an indication of placental health and disease. Placenta. 2014;35(SupplSuppl):S64&#x2013;8. https://doi.org/10.1016/j.placenta.2013.11.014 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.placenta.2013.11.014</ArticleId><ArticleId IdType="pubmed">24388429</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan X, Zhou L, Zhang B, Wang H, Jiang J, Yu B. Early second-trimester plasma cell free DNA levels with subsequent risk of pregnancy complications. Clin Biochem. 2019;71:46&#x2013;51. https://doi.org/10.1016/j.clinbiochem.2019.07.001 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinbiochem.2019.07.001</ArticleId><ArticleId IdType="pubmed">31278894</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan X, Zhou L, Zhang B, Wang H, Yu B, Xu J. Association between low fetal fraction of cell free DNA at the early second-trimester and adverse pregnancy outcomes. Pregnancy Hypertens. 2020;22:101&#x2013;8. https://doi.org/10.1016/j.preghy.2020.07.015 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.preghy.2020.07.015</ArticleId><ArticleId IdType="pubmed">32777709</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Gu X, Wei Y, Tao Y, Zhai B, Peng C, et al. Correlation of low fetal fraction of cell-free DNA at the early second-trimester and pregnancy complications related to placental dysfunction in twin pregnancy. Front Med Lausanne. 2022;9:1011366. https://doi.org/10.3389/fmed.2022.1011366 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.1011366</ArticleId><ArticleId IdType="pubmed">36590958</ArticleId><ArticleId IdType="pmc">9799160</ArticleId></ArticleIdList></Reference><Reference><Citation>Becking EC, Scheffer PG, Henrichs J, Bax CJ, Crombag NMTH, Weiss MM, et al. Fetal fraction of cell-free DNA in noninvasive prenatal testing and adverse pregnancy outcomes: a nationwide retrospective cohort study of 56,110 pregnant women. Am J Obstet Gynecol. 2024;231(2):244. https://doi.org/10.1016/j.ajog.2023.12.008 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2023.12.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Gestational Hypertension and Preeclampsia. ACOG practice Bulletin, number 222. Obstet Gynecol. 2020;135(6):e237&#x2013;60. https://doi.org/10.1097/AOG.0000000000003891 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/AOG.0000000000003891</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan XS, Shi H, Wang HY, Yu B, Jiang J. Ficolin-3/adiponectin ratio for the prediction of gestational diabetes mellitus in pregnant women. J Diabetes Investig. 2018;9(2):403&#x2013;10. https://doi.org/10.1111/jdi.12688 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jdi.12688</ArticleId><ArticleId IdType="pubmed">28445618</ArticleId></ArticleIdList></Reference><Reference><Citation>Horgan R, Bitas C, Abuhamad A. Intrahepatic cholestasis of pregnancy: a comparison of society for Maternal-Fetal medicine and the Royal college of obstetricians and gynaecologists&#x2019; guidelines. Am J Obstet Gynecol MFM. 2023;5(3):100838. https://doi.org/10.1016/j.ajogmf.2022.100838 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajogmf.2022.100838</ArticleId><ArticleId IdType="pubmed">36503152</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong XY, Laivuori H, Livingston JC, Ylikorkala O, Sibai BM, Holzgreve W, et al. Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia. Am J Obstet Gynecol. 2001;184(3):414&#x2013;9. https://doi.org/10.1067/mob.2001.109594 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/mob.2001.109594</ArticleId><ArticleId IdType="pubmed">11228496</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Nakib M, Desbri&#xe8;re R, Bonello N, Bretelle F, Boubli L, Gabert J, et al. Total and fetal cell-free DNA analysis in maternal blood as markers of placental insufficiency in intrauterine growth restriction. Fetal Diagn Ther. 2009;26(1):24&#x2013;8. https://doi.org/10.1159/000236355 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000236355</ArticleId><ArticleId IdType="pubmed">19816026</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazar L, Rig&#xf3; J Jr, Nagy B, Balogh K, Mak&#xf3; V, Cervenak L, et al. Relationship of circulating cell-free DNA levels to cell-free fetal DNA levels, clinical characteristics and laboratory parameters in preeclampsia. BMC Med Genet. 2009;10:120. https://doi.org/10.1186/1471-2350-10-120 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2350-10-120</ArticleId><ArticleId IdType="pubmed">19930583</ArticleId><ArticleId IdType="pmc">2789064</ArticleId></ArticleIdList></Reference><Reference><Citation>Galbiati S, Causarano V, Pinzani P, Francesca S, Orlando C, Smid M, et al. Evaluation of a panel of circulating DNA, RNA and protein potential markers for pathologies of pregnancy. Clin Chem Lab Med. 2010;48(6):791&#x2013;4. https://doi.org/10.1515/CCLM.2010.160 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/CCLM.2010.160</ArticleId><ArticleId IdType="pubmed">20374043</ArticleId></ArticleIdList></Reference><Reference><Citation>Miranda ML, Macher HC, Mu&#xf1;oz-Hern&#xe1;ndez R, Vallejo-Vaz A, Moreno-Luna R, Villar J, et al. Role of circulating cell-free DNA levels in patients with severe preeclampsia and HELLP syndrome. Am J Hypertens. 2013;26(12):1377&#x2013;80. https://doi.org/10.1093/ajh/hpt187 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajh/hpt187</ArticleId><ArticleId IdType="pubmed">24103646</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvianti F, Inversetti A, Smid M, Valsecchi L, Candiani M, Pazzagli M, et al. Prospective evaluation of RASSF1A cell-free DNA as a biomarker of pre-eclampsia. Placenta. 2015;36(9):996&#x2013;1001. https://doi.org/10.1016/j.placenta.2015.07.003 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.placenta.2015.07.003</ArticleId><ArticleId IdType="pubmed">26183647</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SY, Kim HJ, Park SY, Han YJ, Choi JS, Ryu HM. Early prediction of hypertensive disorders of pregnancy using cell-free fetal DNA, cell-free total DNA, and biochemical markers. Fetal Diagn Ther. 2016;40(4):255&#x2013;62. https://doi.org/10.1159/000444524 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000444524</ArticleId><ArticleId IdType="pubmed">26998901</ArticleId></ArticleIdList></Reference><Reference><Citation>AbdelHalim RM, Ramadan DI, Zeyada R, Nasr AS, Mandour IA. Circulating maternal total cell-free DNA, cell-free fetal DNA and soluble endoglin levels in preeclampsia: predictors of adverse fetal outcome?&#xa0;A cohort study. Mol Diagn Ther. 2016;20(2):135&#x2013;49. https://doi.org/10.1007/s40291-015-0184-x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40291-015-0184-x</ArticleId><ArticleId IdType="pubmed">26790664</ArticleId></ArticleIdList></Reference><Reference><Citation>Mu&#xf1;oz-Hern&#xe1;ndez R, Medrano-Campillo P, Miranda ML, Macher HC, Praena-Fern&#xe1;ndez JM, Vallejo-Vaz AJ, et al. Total and fetal circulating cell-free DNA, angiogenic, and antiangiogenic factors in preeclampsia and HELLP syndrome. Am J Hypertens. 2017;30(7):673&#x2013;82. https://doi.org/10.1093/ajh/hpx024 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajh/hpx024</ArticleId><ArticleId IdType="pubmed">28338787</ArticleId></ArticleIdList></Reference><Reference><Citation>Eche S, Mackraj I, Moodley J. Circulating fetal and total cell-free DNA, and sHLA-G in black South African women with gestational hypertension and pre-eclampsia. Hypertens Pregnancy. 2017;36(4):295&#x2013;301. https://doi.org/10.1080/10641955.2017.1385794 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10641955.2017.1385794</ArticleId><ArticleId IdType="pubmed">29115889</ArticleId></ArticleIdList></Reference><Reference><Citation>Rafaeli-Yehudai T, Imterat M, Douvdevani A, Tirosh D, Benshalom-Tirosh N, Mastrolia SA, et al. Maternal total cell-free DNA in preeclampsia and fetal growth restriction: evidence of differences in maternal response to abnormal implantation. PLoS ONE. 2018;13(7):e0200360. https://doi.org/10.1371/journal.pone.0200360 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0200360</ArticleId><ArticleId IdType="pubmed">30001403</ArticleId><ArticleId IdType="pmc">6042756</ArticleId></ArticleIdList></Reference><Reference><Citation>Amaral LM, Sandrim VC, Kutcher ME, Spradley FT, Cavalli RC, Tanus-Santos JE, et al. Circulating total cell-free DNA levels are increased in hypertensive disorders of pregnancy and associated with prohypertensive factors and adverse clinical outcomes. Int J Mol Sci. 2021;22(2):564. https://doi.org/10.3390/ijms22020564 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22020564</ArticleId><ArticleId IdType="pubmed">33429954</ArticleId><ArticleId IdType="pmc">7826953</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolarova TR, Gammill HS, Nelson JL, Lockwood CM, Shree R. At preeclampsia Diagnosis, total Cell-Free DNA concentration is elevated and correlates with disease severity. J Am Heart Assoc. 2021;10(15):e021477. https://doi.org/10.1161/JAHA.121.021477 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.121.021477</ArticleId><ArticleId IdType="pubmed">34310191</ArticleId><ArticleId IdType="pmc">8475684</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalil A, Bellesia G, Norton ME, Jacobsson B, Haeri S, Egbert M, et al. The role of cell-free DNA biomarkers and patient data in the early prediction of preeclampsia: an artificial intelligence model. Am J Obstet Gynecol. 2024;231(5):554. https://doi.org/10.1016/j.ajog.2024.02.299 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2024.02.299</ArticleId></ArticleIdList></Reference><Reference><Citation>Rolnik DL, O&#x2019;Gorman N, Fiolna M, van den Boom D, Nicolaides KH, Poon LC. Maternal plasma cell-free DNA in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol. 2015;45(1):106&#x2013;11. https://doi.org/10.1002/uog.14671 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/uog.14671</ArticleId><ArticleId IdType="pubmed">25252010</ArticleId></ArticleIdList></Reference><Reference><Citation>Silver RM, Myatt L, Hauth JC, Leveno KJ, Peaceman AM, Ramin SM, et al. Cell-Free total and fetal DNA in first trimester maternal serum and subsequent development of preeclampsia. Am J Perinatol. 2017;34(2):191&#x2013;8. https://doi.org/10.1055/s-0035-1570383 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0035-1570383</ArticleId><ArticleId IdType="pubmed">27398706</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwak DW, Kim SY, Kim HJ, Lim JH, Kim YH, Ryu HM. Maternal total cell-free DNA in preeclampsia with and without intrauterine growth restriction. Sci Rep. 2020;10(1):11848. https://doi.org/10.1038/s41598-020-68842-1 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-68842-1</ArticleId><ArticleId IdType="pubmed">32678284</ArticleId><ArticleId IdType="pmc">7367308</ArticleId></ArticleIdList></Reference><Reference><Citation>Karapetian &#x410;&#x41e;, Baev &#x41e;R, Sadekova &#x410;&#x410;, Krasnyi &#x410;&#x41c;, Sukhikh GT. Cell-free foetal DNA as a useful marker for preeclampsia prediction. Reprod Sci. 2021;28(5):1563&#x2013;9. https://doi.org/10.1007/s43032-021-00466-w .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s43032-021-00466-w</ArticleId><ArticleId IdType="pubmed">33475978</ArticleId></ArticleIdList></Reference><Reference><Citation>Sapantzoglou I, Giourga M, Pergialiotis V, Mantzioros R, Daskalaki MA, Papageorgiou D, et al. Low fetal fraction and adverse pregnancy outcomes- systematic review of the literature and metanalysis. Arch Gynecol Obstet. 2024;310(3):1343&#x2013;54. https://doi.org/10.1007/s00404-024-07638-4 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00404-024-07638-4</ArticleId><ArticleId IdType="pubmed">39008086</ArticleId></ArticleIdList></Reference><Reference><Citation>Arbuzova S, Cuckle H. Maternal cell-free DNA in early pregnancy for preeclampsia screening: a systematic review. Arch Gynecol Obstet. 2025;311(5):1249&#x2013;58. https://doi.org/10.1007/s00404-024-07905-4 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00404-024-07905-4</ArticleId><ArticleId IdType="pubmed">39870917</ArticleId><ArticleId IdType="pmc">12033209</ArticleId></ArticleIdList></Reference><Reference><Citation>Rolnik DL, da Silva Costa F, Lee TJ, Schmid M, McLennan AC. Association between fetal fraction on cell-free DNA testing and first-trimester markers for pre-eclampsia. Ultrasound Obstet Gynecol. 2018;52(6):722&#x2013;7. https://doi.org/10.1002/uog.18993 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/uog.18993</ArticleId><ArticleId IdType="pubmed">29318732</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerson KD, Truong S, Haviland MJ, O&#x2019;Brien BM, Hacker MR, Spiel MH. Low fetal fraction of cell-free DNA predicts placental dysfunction and hypertensive disease in pregnancy. Pregnancy Hypertens. 2019;16:148&#x2013;53. https://doi.org/10.1016/j.preghy.2019.04.002 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.preghy.2019.04.002</ArticleId><ArticleId IdType="pubmed">31056151</ArticleId><ArticleId IdType="pmc">10066927</ArticleId></ArticleIdList></Reference><Reference><Citation>Becking EC, Wirjosoekarto SAM, Scheffer PG, Huiskes JVM, Remmelink MJ, Sistermans EA. Low fetal fraction in cell&#x2010;free DNA testing is associated with adverse pregnancy outcome: analysis of a subcohort of the TRIDENT&#x2010;2 study. Prenat Diagn. 2021;41(10):1296&#x2013;304. https://doi.org/10.1002/pd.6034 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pd.6034</ArticleId><ArticleId IdType="pubmed">34426993</ArticleId><ArticleId IdType="pmc">9293122</ArticleId></ArticleIdList></Reference><Reference><Citation>Sapantzoglou I, Gallardo Arozena M, Dragoi V, Akolekar R, Nicolaides KH, Syngelaki A. Fetal fraction of cell free DNA in screening for hypertensive disorders at 11&#x2013;13 weeks. J Matern Fetal Neonatal Med. 2022;35(25):5363&#x2013;8. https://doi.org/10.1080/14767058.2021.1879043 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14767058.2021.1879043</ArticleId><ArticleId IdType="pubmed">33517808</ArticleId></ArticleIdList></Reference><Reference><Citation>Bender WR, Koelper NC, Sammel MD, Dugoff L. Association of fetal fraction of cell-free DNA and hypertensive disorders of pregnancy. Am J Perinatol. 2019;36(3):311&#x2013;6. https://doi.org/10.1055/s-0038-1667374 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0038-1667374</ArticleId><ArticleId IdType="pubmed">30081397</ArticleId></ArticleIdList></Reference><Reference><Citation>Aryavand M, Nurzadeh M, Ghaemi M, Eskandari Delfan S, Marsoosi V. The association between the amount of fetal fraction in cell-free DNA testing and adverse pregnancy outcomes: a cohort study. Int J Reprod Biomed. 2024;22(11):919&#x2013;26. https://doi.org/10.18502/ijrm.v22i11.17824 .</Citation><ArticleIdList><ArticleId IdType="doi">10.18502/ijrm.v22i11.17824</ArticleId><ArticleId IdType="pubmed">39866589</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Werlang A, Cheng W, Lanes A, Wen SW, Walker M. Association between levels of total Cell-Free DNA and development of Preeclampsia-A literature review. AJP Rep. 2021;11(1):e38&#x2013;48. https://doi.org/10.1055/s-0040-1721674 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0040-1721674</ArticleId><ArticleId IdType="pubmed">33747613</ArticleId><ArticleId IdType="pmc">7964254</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheffer PG, Wirjosoekarto SAM, Becking EC, Weiss MM, Bax CJ, Oepkes D, et al. Association between low fetal fraction in cell-free DNA testing and adverse pregnancy outcome: A systematic review. Prenat Diagn. 2021;41(10):1287&#x2013;95. https://doi.org/10.1002/pd.6028 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pd.6028</ArticleId><ArticleId IdType="pubmed">34350596</ArticleId><ArticleId IdType="pmc">9292009</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">41225082</PMID><DateRevised><Year>2025</Year><Month>11</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1933-7205</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Nov</Month><Day>12</Day></PubDate></JournalIssue><Title>Reproductive sciences (Thousand Oaks, Calif.)</Title><ISOAbbreviation>Reprod Sci</ISOAbbreviation></Journal><ArticleTitle>The Effect of Prenatal Dexamethasone Exposure on Placental Morphology and Function at Different Stages, Doses, and Courses In Mice.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s43032-025-02006-2</ELocationID><Abstract><AbstractText>The "double-edged sword" effect of dexamethasone on fetal development has attracted significant attention. Currently, the "one-size-fits-all" prenatal corticosteroid regimen fails to confer uniform benefits to all pregnant women and fetuses. Simultaneously, there exist controversies regarding the wide time window for administration and the insufficient consideration of individual factors in dosage selection. Therefore, this study aimed to establish a precise prenatal dexamethasone exposure (PDE) mouse model that closely mimics clinical use, to evaluate its effects on placental morphology, development, differentiation, vascular formation, and nutrient transporter function. Dexamethasone was injected subcutaneously at diverse gestational stages, doses, and courses. The late-stage, high-dose, single-course PDE exhibited the most pronounced effects, including reduced placental weight, a decreased labyrinth-to-junctional zone (LZ/JZ) ratio, impaired trophoblast proliferation and differentiation, increased apoptosis, and decreased vascular endothelial growth factor (VEGF) expression. Amino acid and cholesterol transporter levels increased in both sexes, whereas glucose transporters showed sex-specific alterations-elevated in males but reduced in females. Further investigation revealed that PDE suppressed the "glucocorticoid (GC)-insulin-like growth factor 1 (IGF1) axis" programming, which was highly correlated with placental development and function indicators. In conclusion, PDE induced alterations in placental morphology, development, and nutrient transport function, which were influenced by stages, doses, courses, and sex differences. These changes may be associated with the "GC-IGF1 axis" programming. This study provides experimental and theoretical evidence to more precisely guide the clinical application of prenatal dexamethasone.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s), under exclusive licence to Society for Reproductive Investigation.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Hui</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Reproductive Medicine Center, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Yuhong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Basic Medical School of Wuhan University, Wuhan, 430071, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Xiaoqi</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Basic Medical School of Wuhan University, Wuhan, 430071, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ge</LastName><ForeName>Caiyun</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Reproductive Medicine Center, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhong</LastName><ForeName>Wen</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Reproductive Medicine Center, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zha</LastName><ForeName>Xiaomeng</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Reproductive Medicine Center, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fang</LastName><ForeName>Man</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Reproductive Medicine Center, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Hui</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Reproductive Medicine Center, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China. wanghui19@whu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacology, Basic Medical School of Wuhan University, Wuhan, 430071, China. wanghui19@whu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hubei Provincial Key Laboratory of Developmentally Originated Diseases, Wuhan, 430071, China. wanghui19@whu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Ming</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-1867-9782</Identifier><AffiliationInfo><Affiliation>Reproductive Medicine Center, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China. whu_mz@163.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hubei Provincial Key Laboratory of Developmentally Originated Diseases, Wuhan, 430071, China. whu_mz@163.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hubei Clinical Research Center for Prenatal Diagnosis and Birth Health, Wuhan, 430071, China. whu_mz@163.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Wuhan Clinical Research Center for Reproductive Science and Birth Health, Wuhan, 430071, China. whu_mz@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>No. 2020YFA0803900</GrantID><Agency>National Key R&amp;D Program of China</Agency><Country/></Grant><Grant><GrantID>No. 82071659</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>No. ZNLH202206</GrantID><Agency>Basic and Clinical Medical Research Joint Fund of Zhongnan Hospital</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>11</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Reprod Sci</MedlineTA><NlmUniqueID>101291249</NlmUniqueID><ISSNLinking>1933-7191</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Developmental toxicity</Keyword><Keyword MajorTopicYN="N">GC-IGF1 axis programming</Keyword><Keyword MajorTopicYN="N">Placental development</Keyword><Keyword MajorTopicYN="N">Prenatal dexamethasone exposure</Keyword></KeywordList><CoiStatement>Declarations. Ethical Approval: All animal experiments in this study were reviewed and approved by the Animal Experiment Ethics Committee of Wuhan University School of Medicine (Approval number: WP20210061). The experiments were conducted in accordance with the institutional and national guidelines for the care and use of laboratory animals, following the Guidelines for the Care and Use of Laboratory Animals set by the Chinese Animal Welfare Committee. The study was performed at the Wuhan University Animal Testing Center, an accredited by AAALAC International). Consent to Participate: Not applicable. Consent for Publication: Not applicable. Conflict of Interest: The authors have no competing interests to declare that are relevant to the content of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>3</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>10</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>11</Month><Day>13</Day><Hour>0</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>11</Month><Day>13</Day><Hour>0</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>11</Month><Day>12</Day><Hour>23</Hour><Minute>36</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">41225082</ArticleId><ArticleId IdType="doi">10.1007/s43032-025-02006-2</ArticleId><ArticleId IdType="pii">10.1007/s43032-025-02006-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alur P. Sex differences in nutrition, growth, and metabolism in preterm infants. Front Pediatr. 2019;7:22. https://doi.org/10.3389/fped.2019.00022 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2019.00022</ArticleId><ArticleId IdType="pubmed">30792973</ArticleId><ArticleId IdType="pmc">6374621</ArticleId></ArticleIdList></Reference><Reference><Citation>Boggess KA, Kay HH, Crapo JD, Moore WF, Suliman HB, Oury TD. Differential localization of placental extracellular superoxide dismutase as pregnancy progresses. Am J Obstet Gynecol. 2000;183:199&#x2013;205. https://doi.org/10.1067/mob.2000.105426 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/mob.2000.105426</ArticleId><ArticleId IdType="pubmed">10920331</ArticleId></ArticleIdList></Reference><Reference><Citation>Braun AE, Mitchel OR, Gonzalez TL, Sun T, Flowers AE, Pisarska MD, et al. Sex at the interface: the origin and impact of sex differences in the developing human placenta. Biol Sex Differ. 2022;13:50. https://doi.org/10.1186/s13293-022-00459-7 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13293-022-00459-7</ArticleId><ArticleId IdType="pubmed">36114567</ArticleId><ArticleId IdType="pmc">9482177</ArticleId></ArticleIdList></Reference><Reference><Citation>Burton GJ, Charnock-Jones DS, Jauniaux E. Regulation of vascular growth and function in the human placenta. Reproduction. 2009;138:895&#x2013;902. https://doi.org/10.1530/rep-09-0092 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/rep-09-0092</ArticleId><ArticleId IdType="pubmed">19470597</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciapponi A, Klein K, Colaci D, Althabe F, Beliz&#xe1;n JM, Deegan A, et al. Dexamethasone versus betamethasone for preterm birth: a systematic review and network meta-analysis. Am J Obstet Gynecol MFM. 2021;3:100312. https://doi.org/10.1016/j.ajogmf.2021.100312 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajogmf.2021.100312</ArticleId><ArticleId IdType="pubmed">33482400</ArticleId></ArticleIdList></Reference><Reference><Citation>Clifton VL. Sex and the human placenta: mediating differential strategies of fetal growth and survival. Placenta. 2010;31(Suppl):S33-39. https://doi.org/10.1016/j.placenta.2009.11.010 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.placenta.2009.11.010</ArticleId><ArticleId IdType="pubmed">20004469</ArticleId></ArticleIdList></Reference><Reference><Citation>Coan PM, Angiolini E, Sandovici I, Burton GJ, Const&#xe2;ncia M, Fowden AL. Adaptations in placental nutrient transfer capacity to meet fetal growth demands depend on placental size in mice. J Physiol. 2008;586:4567&#x2013;76. https://doi.org/10.1113/jphysiol.2008.156133 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2008.156133</ArticleId><ArticleId IdType="pubmed">18653658</ArticleId><ArticleId IdType="pmc">2614013</ArticleId></ArticleIdList></Reference><Reference><Citation>Coutifaris C, Kao LC, Sehdev HM, Chin U, Babalola GO, Blaschuk OW, et al. E-cadherin expression during the differentiation of human trophoblasts. Development. 1991;113:767&#x2013;77. https://doi.org/10.1242/dev.113.3.767 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.113.3.767</ArticleId><ArticleId IdType="pubmed">1821848</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuffe JS, O&#x2019;Sullivan L, Simmons DG, Anderson ST, Moritz KM. Maternal corticosterone exposure in the mouse has sex-specific effects on placental growth and mrna expression. Endocrinology. 2012;153:5500&#x2013;11. https://doi.org/10.1210/en.2012-1479 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/en.2012-1479</ArticleId><ArticleId IdType="pubmed">22919064</ArticleId></ArticleIdList></Reference><Reference><Citation>Florio P, Severi FM, Ciarmela P, Fiore G, Calonaci G, Merola A, et al. Placental stress factors and maternal-fetal adaptive response: the corticotropin-releasing factor family. Endocrine. 2002;19(1):91&#x2013;102. https://doi.org/10.1385/endo:19:1:91 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1385/endo:19:1:91</ArticleId><ArticleId IdType="pubmed">12583606</ArticleId></ArticleIdList></Reference><Reference><Citation>Fowden AL, Sferruzzi-Perri AN, Coan PM, Constancia M, Burton GJ. Placental efficiency and adaptation: endocrine regulation. J Physiol. 2009;587:3459&#x2013;72. https://doi.org/10.1113/jphysiol.2009.173013 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2009.173013</ArticleId><ArticleId IdType="pubmed">19451204</ArticleId><ArticleId IdType="pmc">2742275</ArticleId></ArticleIdList></Reference><Reference><Citation>Fowden AL, Valenzuela OA, Vaughan OR, Jellyman JK, Forhead AJ. Glucocorticoid programming of intrauterine development. Domest Anim Endocrinol. 2016;56(Suppl):S121-132. https://doi.org/10.1016/j.domaniend.2016.02.014 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.domaniend.2016.02.014</ArticleId><ArticleId IdType="pubmed">27345310</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaccioli F, Lager S, Powell TL, Jansson T. Placental transport in response to altered maternal nutrition. J Dev Orig Health Dis. 2013;4:101&#x2013;15. https://doi.org/10.1017/s2040174412000529 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s2040174412000529</ArticleId><ArticleId IdType="pubmed">25054676</ArticleId><ArticleId IdType="pmc">4237017</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xe5;rdebjer EM, Cuffe JS, Pantaleon M, Wlodek ME, Moritz KM. Periconceptional alcohol consumption causes fetal growth restriction and increases glycogen accumulation in the late gestation rat placenta. Placenta. 2014;35:50&#x2013;7. https://doi.org/10.1016/j.placenta.2013.10.008 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.placenta.2013.10.008</ArticleId><ArticleId IdType="pubmed">24239160</ArticleId></ArticleIdList></Reference><Reference><Citation>Gauster M, Moser G, Wernitznig S, Kupper N, Huppertz B. Early human trophoblast development: from morphology to function. Cell Mol Life Sci. 2022;79:345. https://doi.org/10.1007/s00018-022-04377-0 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-022-04377-0</ArticleId><ArticleId IdType="pubmed">35661923</ArticleId><ArticleId IdType="pmc">9167809</ArticleId></ArticleIdList></Reference><Reference><Citation>Gude NM, Roberts CT, Kalionis B, King RG. Growth and function of the normal human placenta. Thromb Res. 2004;114:397&#x2013;407. https://doi.org/10.1016/j.thromres.2004.06.038 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2004.06.038</ArticleId><ArticleId IdType="pubmed">15507270</ArticleId></ArticleIdList></Reference><Reference><Citation>Gundogan F, Gilligan J, Qi W, Chen E, Naram R, de la Monte SM. Dose effect of gestational ethanol exposure on placentation and fetal growth. Placenta. 2015;36:523&#x2013;30. https://doi.org/10.1016/j.placenta.2015.02.010 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.placenta.2015.02.010</ArticleId><ArticleId IdType="pubmed">25745824</ArticleId><ArticleId IdType="pmc">4416060</ArticleId></ArticleIdList></Reference><Reference><Citation>Hallman M. The story of antenatal steroid therapy before preterm birth. Neonatology. 2015;107:352&#x2013;7. https://doi.org/10.1159/000381130 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000381130</ArticleId><ArticleId IdType="pubmed">26044103</ArticleId></ArticleIdList></Reference><Reference><Citation>Hewitt DP, Mark PJ, Waddell BJ. Glucocorticoids prevent the normal increase in placental vascular endothelial growth factor expression and placental vascularity during late pregnancy in the rat. Endocrinology. 2006;147:5568&#x2013;74. https://doi.org/10.1210/en.2006-0825 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/en.2006-0825</ArticleId><ArticleId IdType="pubmed">16959835</ArticleId></ArticleIdList></Reference><Reference><Citation>Hrabalkova L, Takahashi T, Kemp MW, Stock SJ. Antenatal corticosteroids for fetal lung maturity - too much of a good thing? Curr Pharm Des. 2019;25(5):593&#x2013;600. https://doi.org/10.2174/1381612825666190326143814 .</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612825666190326143814</ArticleId><ArticleId IdType="pubmed">30914016</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Z, Huang S, Song T, Yin Y, Tan C. Placental angiogenesis in mammals: a review of the regulatory effects of signaling pathways and functional nutrients. Adv Nutr. 2021;12:2415&#x2013;34. https://doi.org/10.1093/advances/nmab070 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/advances/nmab070</ArticleId><ArticleId IdType="pubmed">34167152</ArticleId><ArticleId IdType="pmc">8634476</ArticleId></ArticleIdList></Reference><Reference><Citation>Illsley NP, Baumann MU. Human placental glucose transport in fetoplacental growth and metabolism. Biochimica et Biophysica Acta (BBA). 2020;1866:165359. https://doi.org/10.1016/j.bbadis.2018.12.010 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2018.12.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalisch-Smith JI, Simmons DG, Dickinson H, Moritz KM. Sexual dimorphism in the formation, function and adaptation of the placenta. Placenta. 2017;54:10&#x2013;6. https://doi.org/10.1016/j.placenta.2016.12.008 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.placenta.2016.12.008</ArticleId><ArticleId IdType="pubmed">27979377</ArticleId></ArticleIdList></Reference><Reference><Citation>Kent NL, Atluri SC, Moritz KM, Cuffe JSM. Maternal hypothyroidism in rats impairs placental nutrient transporter expression, increases labyrinth zone size, and impairs fetal growth. Placenta. 2023;139:148&#x2013;58. https://doi.org/10.1016/j.placenta.2023.06.010 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.placenta.2023.06.010</ArticleId><ArticleId IdType="pubmed">37406552</ArticleId></ArticleIdList></Reference><Reference><Citation>Lapehn S, Paquette AG. The placental epigenome as a molecular link between prenatal exposures and fetal health outcomes through the DOHaD hypothesis. Curr Environ Health Rep. 2022;9:490&#x2013;501. https://doi.org/10.1007/s40572-022-00354-8 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40572-022-00354-8</ArticleId><ArticleId IdType="pubmed">35488174</ArticleId><ArticleId IdType="pmc">9363315</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung TN, Lam PM, Ng PC, Lau TK. Repeated courses of antenatal corticosteroids: is it justified? Acta Obstet Gynecol Scand. 2003;82:589&#x2013;96. https://doi.org/10.1034/j.1600-0412.2003.00204.x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1600-0412.2003.00204.x</ArticleId><ArticleId IdType="pubmed">12790838</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S, Sloboda DM, Moss TJ, Nitsos I, Polglase GR, Doherty DA, et al. Effects of glucocorticoid treatment given in early or late gestation on growth and development in sheep. J Dev Orig Health Dis. 2013;4:146&#x2013;56. https://doi.org/10.1017/s204017441200075x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s204017441200075x</ArticleId><ArticleId IdType="pubmed">25054681</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Zhang C, Liu Y, Zhu J, Qu H, Zhou S, et al. Paternal nicotine/ethanol/caffeine mixed exposure induces offspring rat dysplasia and its potential &#x201c;gc-igf1&#x201d; programming mechanism. Int J Mol Sci. 2022. https://doi.org/10.3390/ijms232315081 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms232315081</ArticleId><ArticleId IdType="pubmed">36614339</ArticleId><ArticleId IdType="pmc">9820820</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Tello J, Sferruzzi-Perri A. Histological analysis of trophoblast cells in the mouse placental labyrinth zone. Methods Mol Biol. 2024;2781:1&#x2013;13. https://doi.org/10.1007/978-1-0716-3746-3_1 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-0716-3746-3_1</ArticleId><ArticleId IdType="pubmed">38502438</ArticleId></ArticleIdList></Reference><Reference><Citation>Mateos RM, Jim&#xe9;nez G, &#xc1;lvarez-Gil C, Visiedo F, Rivera-Rodr&#xed;guez F, Santos-Rosendo C, et al. Excess hydrocortisone hampers placental nutrient uptake disrupting cellular metabolism. BioMed Res Int. 2018;2018:5106174. https://doi.org/10.1155/2018/5106174 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/5106174</ArticleId><ArticleId IdType="pubmed">30402483</ArticleId><ArticleId IdType="pmc">6198558</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Connell BA, Moritz KM, Roberts CT, Walker DW, Dickinson H. The placental response to excess maternal glucocorticoid exposure differs between the male and female conceptus in spiny mice. Biol Reprod. 2011;85:1040&#x2013;7. https://doi.org/10.1095/biolreprod.111.093369 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1095/biolreprod.111.093369</ArticleId><ArticleId IdType="pubmed">21795670</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Connell BA, Moritz KM, Walker DW, Dickinson H. Synthetic glucocorticoid dexamethasone inhibits branching morphogenesis in the spiny mouse placenta. Biol Reprod. 2013;88:26. https://doi.org/10.1095/biolreprod.112.100644 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1095/biolreprod.112.100644</ArticleId><ArticleId IdType="pubmed">23242523</ArticleId></ArticleIdList></Reference><Reference><Citation>Committee on Obstetric Practice. Committee opinion No. 713: antenatal corticosteroid therapy for fetal maturation. Obstet Gynecol. 2017;130(2):e102&#x2013;e109. https://doi.org/10.1097/aog.0000000000002237</Citation></Reference><Reference><Citation>Petropoulos S, Edsg&#xe4;rd D, Reinius B, Deng Q, Panula SP, Codeluppi S, et al. Single-cell rna-seq reveals lineage and x chromosome dynamics in human preimplantation embryos. Cell. 2016;165:1012&#x2013;26. https://doi.org/10.1016/j.cell.2016.03.023 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.03.023</ArticleId><ArticleId IdType="pubmed">27062923</ArticleId><ArticleId IdType="pmc">4868821</ArticleId></ArticleIdList></Reference><Reference><Citation>Randhawa R, Cohen P. The role of the insulin-like growth factor system in prenatal growth. Mol Genet Metab. 2005;86:84&#x2013;90. https://doi.org/10.1016/j.ymgme.2005.07.028 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymgme.2005.07.028</ArticleId><ArticleId IdType="pubmed">16165387</ArticleId></ArticleIdList></Reference><Reference><Citation>Ray PF, Conaghan J, Winston RM, Handyside AH. Increased number of cells and metabolic activity in male human preimplantation embryos following in vitro fertilization. J Reprod Fertil. 1995;104:165&#x2013;71. https://doi.org/10.1530/jrf.0.1040165 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/jrf.0.1040165</ArticleId><ArticleId IdType="pubmed">7636798</ArticleId></ArticleIdList></Reference><Reference><Citation>Reuss B, Hellmann P, Dahl E, Traub O, Butterweck A, Gr&#xfc;mmer R, et al. Connexins and E-cadherin are differentially expressed during trophoblast invasion and placenta differentiation in the rat. Dev Dyn. 1996;205:172&#x2013;82. https://doi.org/10.1002/(sici)1097-0177(199602)205:2%3c172::Aid-aja8%3e3.0.Co;2-f .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(sici)1097-0177(199602)205:2&lt;172::Aid-aja8&gt;3.0.Co;2-f</ArticleId><ArticleId IdType="pubmed">8834477</ArticleId></ArticleIdList></Reference><Reference><Citation>Sferruzzi-Perri AN, Owens JA, Pringle KG, Robinson JS, Roberts CT. Maternal insulin-like growth factors-I and -II act via different pathways to promote fetal growth. Endocrinology. 2006;147:3344&#x2013;55. https://doi.org/10.1210/en.2005-1328 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/en.2005-1328</ArticleId><ArticleId IdType="pubmed">16556757</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimada H, Powell TL, Jansson T. Regulation of placental amino acid transport in health and disease. Acta Physiol (Oxf). 2024;240:e14157. https://doi.org/10.1111/apha.14157 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apha.14157</ArticleId><ArticleId IdType="pubmed">38711335</ArticleId></ArticleIdList></Reference><Reference><Citation>Simmons DG, Natale DR, Begay V, Hughes M, Leutz A, Cross JC. Early patterning of the chorion leads to the trilaminar trophoblast cell structure in the placental labyrinth. Development. 2008;135:2083&#x2013;91. https://doi.org/10.1242/dev.020099 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.020099</ArticleId><ArticleId IdType="pubmed">18448564</ArticleId></ArticleIdList></Reference><Reference><Citation>Slob EMA, Termote JUM, Nijkamp JW, Van der Kamp HJ, van den Akker ELT. Safety of antenatal predniso(lo)ne and dexamethasone on fetal, neonatal and childhood outcomes: a systematic review. J Clin Endocrinol Metab. 2023. https://doi.org/10.1210/clinem/dgad547 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgad547</ArticleId></ArticleIdList></Reference><Reference><Citation>Stark MJ, Hodyl NA, Wright IM, Clifton VL. Influence of sex and glucocorticoid exposure on preterm placental pro-oxidant-antioxidant balance. Placenta. 2011;32:865&#x2013;70. https://doi.org/10.1016/j.placenta.2011.08.010 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.placenta.2011.08.010</ArticleId><ArticleId IdType="pubmed">21903264</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun C, Groom KM, Oyston C, Chamley LW, Clark AR, James JL. The placenta in fetal growth restriction: what is going wrong? Placenta. 2020;96:10&#x2013;8. https://doi.org/10.1016/j.placenta.2020.05.003 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.placenta.2020.05.003</ArticleId><ArticleId IdType="pubmed">32421528</ArticleId></ArticleIdList></Reference><Reference><Citation>Trifunovi&#x107; S, &#x160;o&#x161;i&#x107; Jurjevi&#x107; B, Risti&#x107; N, Nestorovi&#x107; N, Filipovi&#x107; B, Stevanovi&#x107; I, et al. Maternal dexamethasone exposure induces sex-specific changes in histomorphology and redox homeostasis of rat placenta. Int J Mol Sci. 2022. https://doi.org/10.3390/ijms24010540 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24010540</ArticleId><ArticleId IdType="pubmed">36613982</ArticleId><ArticleId IdType="pmc">9820254</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaughan OR, Sferruzzi-Perri AN, Coan PM, Fowden AL. Adaptations in placental phenotype depend on route and timing of maternal dexamethasone administration in mice. Biol Reprod. 2013;89:80. https://doi.org/10.1095/biolreprod.113.109678 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1095/biolreprod.113.109678</ArticleId><ArticleId IdType="pubmed">23986571</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Chen F, Zhu S, Li X, Shi W, Dai Z, et al. Adverse effects of prenatal dexamethasone exposure on fetal development. J Reprod Immunol. 2022;151:103619. https://doi.org/10.1016/j.jri.2022.103619 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jri.2022.103619</ArticleId><ArticleId IdType="pubmed">35367871</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao Z, Yan L, Liang X, Wang H. Progress in deciphering trophoblast cell differentiation during human placentation. Curr Opin Cell Biol. 2020;67:86&#x2013;91. https://doi.org/10.1016/j.ceb.2020.08.010 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ceb.2020.08.010</ArticleId><ArticleId IdType="pubmed">32957014</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang G, Zhou J, Huang W, Fang M, Yu L, Wang H, et al. Prenatal ethanol exposure-induced a low level of foetal blood cholesterol and its mechanism of igf1-related placental cholesterol transport dysfunction. Toxicology. 2019;424:152237. https://doi.org/10.1016/j.tox.2019.152237 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tox.2019.152237</ArticleId><ArticleId IdType="pubmed">31226463</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao X, Xiao H, Li X, Zhu L, Peng Y, Chen H, et al. Multi-organ developmental toxicity and its characteristics in fetal mice induced by dexamethasone at different doses, stages, and courses during pregnancy. Arch Toxicol. 2024;98:1891&#x2013;908. https://doi.org/10.1007/s00204-024-03707-4 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00204-024-03707-4</ArticleId><ArticleId IdType="pubmed">38522057</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>